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“Everything	  here	  is	  so	  cold	  
Everything	  here	  is	  so	  dark”	  
	  [Mayhem,	  The	  freezing	  moon,	  De	  mysteriis	  dom	  sathanas	  [CD],	  Deathlike	  silence,	  Oslo	  1994]	  
	  
Tromsø	  certainly	  can	  be	  both	  a	  bit	  cold	  and	  a	  bit	  dark	  at	  certain	  time	  intervals.	  
Luckily,	  several	  people	  have	  contributed	  to	  lighten	  spirits	  in	  the	  daily	  PhD	  life	  
during	  my	  stay	  at	  department	  of	  pharmacy.	  
I	  have	  had	  the	  pleasure	  of	  working	  close	  with	  a	  multitude	  of	  experts.	  Researchers	  
in	  epidemiology,	  molecular	  biology,	  evolution,	  mathematical	  modelling,	  clinical	  
pharmacy	  and	  statistics	  have	  joyfully	  helped	  me	  and	  joined	  in	  all	  my	  outbursts	  of	  
scientific	  discussions.	  	  
I	  am	  especially	  grateful	  to	  my	  two	  supervisors	  Raul	  Primicerio	  and	  Lars	  
Småbrekke.	  Raul’s	  infectious	  enthusiasm	  and	  positive	  attitude	  have	  elevated	  the	  
statistical	  discussions	  in	  my	  office	  to	  rock	  concert	  volumes	  (ask	  my	  neighbouring	  
offices,	  they	  know	  when	  Raul	  is	  supervising	  me).	  Without	  Raul’s	  positive	  attitude	  
and	  statistical	  knowledge	  this	  project	  would	  have	  been	  much,	  much	  duller.	  	  
Lars	  has	  a	  keen	  eye	  for	  details	  (which	  I	  tend	  to	  lack)	  and	  has	  been	  an	  exceptional	  
motivator	  for	  finishing	  the	  projects.	  Besides	  guidance	  through	  epidemiology,	  his	  
enthusiasm	  for	  new	  methodology	  and	  care	  for	  the	  tired	  PhD	  student	  has	  been	  of	  
great	  value.	  The	  close	  contact	  and	  friendship	  has	  been	  much	  appreciated.	  
Pål	  Johnsen	  guided	  me	  through	  my	  first	  project	  and	  the	  cooperation	  with	  Pål	  and	  
Irina	  was	  a	  great	  experience	  and	  is	  a	  fond	  memory.	  Thank	  you	  for	  delightful	  
discussions	  and	  expert	  supervision.	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The	  collaboration	  with	  Gunnar	  Skov	  Simonsen	  and	  Anne-­‐Sofie	  Furberg	  has	  been	  
much	  appreciated.	  Your	  rapid,	  detailed	  responses	  and	  insightful	  comments	  have	  
truly	  helped	  me	  in	  developing	  the	  projects.	  	  
Vidar	  Sørum	  has	  been	  a	  keen	  partner	  for	  discussions,	  methodological	  
considerations,	  (a	  multitude	  of)	  frustrations	  and	  general	  tomfoolery.	  Thank	  you	  
for	  a	  long	  lasting	  friendship	  and	  your	  patience	  with	  my	  lengthy	  explanations	  of	  
methodology.	  
Kaare,	  Marit,	  Klaus,	  Nils,	  Beate,	  June,	  Kjell	  and	  Frode	  and	  all	  members	  of	  the	  
MMPE	  research	  group:	  thank	  you	  for	  the	  discussions	  and	  quick	  responses	  on	  all	  
of	  my	  questions.	  	  
Dear	  colleagues	  at	  the	  department	  of	  pharmacy,	  I	  wish	  you	  all	  the	  best,	  thank	  you	  
for	  four	  fantastic,	  yet	  challenging	  years.	  
Finally,	  the	  importance	  of	  the	  work	  being	  put	  into	  creating,	  updating	  and	  
developing	  the	  R	  language	  for	  statistical	  computing	  cannot	  be	  underestimated.	  	  
This	  is	  an	  “easy”	  programming	  language	  that	  is	  free	  to	  use	  for	  anybody	  and	  is	  
continuously	  updated	  by	  enthusiasts.	  Open	  source	  software	  has	  become	  an	  
important	  part	  of	  my	  scientific	  thinking;	  I	  wish	  I	  had	  the	  knowledge	  to	  
implement	  such	  programs	  in	  an	  even	  broader	  manner	  than	  I	  have	  done.	  To	  all	  
developers	  of	  R,	  thank	  you,	  and	  keep	  up	  the	  good	  work!	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Terminology	  and	  abbreviations	  
The	  word	  antibiotics	  may	  lack	  precision	  in	  some	  circumstances;	  in	  this	  thesis	  
antibiotic	  refers	  to	  compounds	  used	  against	  infections	  caused	  by	  bacteria.1	  	  
The	  Defined	  Daily	  Dose	  (DDD)	  is	  used	  as	  a	  measure	  for	  antibiotic	  consumption.	  
The	  World	  Health	  Organization	  (WHO)	  defines	  DDD	  as	  	  “the	  assumed	  average	  
maintenance	  dose	  per	  day	  for	  a	  drug	  used	  for	  its	  main	  indication	  in	  adults”.2	  
	  
AIC	   	   Akaike	  Information	  Criteria	  
ATC	   	   Anatomical	  Therapeutic	  Chemical	  classification	  system	  
CA	   	   Correspondence	  Analysis	  
CCA	   	   Constrained	  Correspondence	  Analysis	  
CDC	   	   Centres	  for	  Disease	  Control	  and	  prevention	  
CRE	   	   Carbapenem-­‐Resistant	  Enterobateriaceae	  
DAG	   	   Directed	  Acyclic	  Graph	  
DDD	   	   Defined	  Daily	  Dose	  
DID	   	   DDD	  /	  1000	  inhabitants	  /	  day	  
ECDC	   	   European	  Centre	  for	  Disease	  prevention	  and	  Control	  
ESAC	   	   European	  Surveillance	  of	  Antimicrobial	  Consumption	  
GP	   	   General	  Practitioner	  
HGT	   	   Horizontal	  Gene	  Transfer	  
MAUP	   	   Modifiable	  Areal	  Unit	  Problem	  
NorPD	  	   Norwegian	  Prescription	  Database	  
OLS	   	   Ordinary	  Least	  Squares	  
OR	   	   Odds	  Ratio	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QR	   	   Quantile	  Regression	  
UK	   	   United	  Kingdom	  
US	   	   United	  States	  
WHO	   	   World	  Health	  Organisation	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Introduction	  
Antibiotic	  resistance	  in	  bacteria	  is	  a	  prime	  example	  of	  the	  implications	  of	  
Darwin’s	  theory	  of	  evolution:	  A	  selective	  pressure	  will	  change	  the	  frequency	  of	  
genotypes	  in	  a	  population	  in	  favour	  of	  the	  organisms	  that	  are	  best	  adapted	  to	  the	  
environment.3,	  4	  In	  presence	  of	  antibiotics	  the	  resistant	  phenotypes	  have	  an	  
advantage	  over	  their	  susceptible	  counterparts,	  and	  can	  potentially	  dominate	  the	  
environment	  in	  relatively	  short	  time.5	  Antibiotic	  resistance	  and	  related	  genes	  
predates	  human	  antibiotic	  production	  and	  use,	  and	  resistant	  bacteria	  are	  even	  
found	  in	  environments	  where	  human	  impact	  is	  improbable.6,	  7	  However,	  
evidence	  for	  human	  activities	  as	  drivers	  of	  increased	  levels	  of	  antibiotic	  
resistance	  is	  overwhelming,	  even	  though	  some	  reports	  show	  that	  the	  link	  
between	  consumption	  and	  resistance	  is	  not	  always	  clear-­‐cut.3,	  8-­‐16	  
	  
Antibiotic	  use	  
Antibiotics	  are	  commonly	  used	  in	  agriculture	  and	  aquaculture	  as	  well	  as	  for	  
human	  consumption.	  In	  Germany	  in	  2008,	  85%	  of	  the	  total	  sales	  of	  antibiotics	  
were	  used	  for	  animals.	  In	  contrast,	  Norwegian	  and	  Swedish	  antibiotic	  sales	  to	  
animals	  in	  2012	  constituted	  15%	  of	  total	  sales.11,	  17,	  18	  In	  Denmark	  the	  sales	  of	  
antibiotics	  for	  animal	  consumption	  constituted	  70%	  of	  the	  volume	  sold	  in	  
2012.19	  
Human	  antibiotic	  consumption	  can	  be	  divided	  into	  hospital	  and	  outpatient	  use.	  
Of	  the	  total	  human	  consumption	  in	  Norway	  approximately	  80%	  is	  from	  
outpatients.17,	  20	  	  
In	  Norway	  the	  total	  consumption	  of	  antibiotics	  is	  relatively	  stable.	  There	  was	  an	  
increase	  from	  19	  DDD	  /	  1000	  patients	  /day	  (DID),	  in	  2006	  to	  20	  DID	  in	  2013.	  
However,	  methenamine	  (Anatomical	  Therapeutic	  chemical	  Classification	  system	  
(ATC)	  class	  J01XX05)	  is	  frequently	  used	  in	  Norway	  for	  prevention	  of	  urinary	  
tract	  infections.	  The	  antibiotic	  consumption	  excluding	  this	  drug	  was	  16.3	  both	  in	  
2006	  and	  2013.17	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A	  major	  task	  to	  combat	  evolution	  of	  antibiotic	  resistance	  is	  to	  monitor	  resistance	  
in	  bacteria.	  Also,	  monitoring	  consumption	  of	  antibiotics	  is	  important	  to	  identify	  
countries,	  regions	  or	  demographic	  groups	  with	  an	  undesirable	  consumption.	  
Reports	  on	  consumption	  of	  antibiotics	  can	  be	  based	  on	  sales	  from	  wholesalers,	  
reimbursements	  or	  prescription	  databases.	  If	  sold	  antibiotics	  are	  consumed	  is	  
seldom	  investigated.	  A	  global	  study	  on	  adherence	  to	  acne	  treatment	  revealed	  
adherence	  as	  low	  as	  50%.21	  Other	  reports	  show	  non-­‐adherence	  as	  low	  as	  9%	  for	  
patients	  receiving	  antibiotic	  treatment.22	  
	  To	  what	  extent	  sales	  of	  antibiotics	  reflects	  the	  accurate	  consumption	  will	  vary	  
depending	  on	  indication,	  how	  many	  and	  frequency	  of	  doses,	  if	  the	  patient	  feels	  
healthy,	  possible	  side	  effects	  of	  the	  drug	  and	  also	  personality.22,	  23	  Therefore,	  
some	  uncertainty	  is	  connected	  to	  measurements	  of	  antibiotic	  consumption.	  Most	  
data	  on	  antibiotic	  consumption	  are	  therefore	  an	  estimate	  of	  the	  true	  
consumption.	  	  
The	  European	  Centre	  for	  Disease	  prevention	  and	  Control	  (ECDC)	  have	  published	  
data	  on	  consumption	  of	  antibiotics	  in	  several	  European	  countries.24	  With	  a	  few	  
exceptions	  the	  figures	  only	  cover	  outpatient	  consumption.	  No	  decrease	  in	  the	  
consumption	  of	  antibiotics	  was	  found	  in	  22	  countries	  during	  2007	  –	  2011.	  In	  
2011	  Greece	  and	  Belgium	  were	  among	  the	  highest	  consuming	  countries,	  with	  
approximately	  30	  DID,	  whereas	  Netherlands	  and	  Estonia	  consumed	  less	  than	  
half	  of	  this,	  approximately	  12	  DID.24	  A	  large	  difference	  in	  the	  ratio	  of	  broad-­‐	  
versus	  narrow	  spectrum	  antibiotic	  use	  was	  identified.	  Sweden	  and	  Norway	  had	  a	  
ratio	  of	  0.2	  and	  Malta	  a	  ratio	  of	  142.7.24	  The	  data	  on	  antibiotic	  use	  in	  European	  
countries	  are	  presented	  in	  more	  detail	  in	  Box1.	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Box	  1	  Antibiotic	  profiles	  of	  European	  countries	  based	  on	  ECDC	  2011	  data	  
1
The	  ECDC	  2014	  report	  (Table	  3.1)	  presents	  data	  on	  DID	  for	  8	  subgroups	  of	  antibiotics	  from	  29	  
countries.	  [1]	  In	  the	  following	  the	  data	  have	  been	  processed	  by	  correspondence	  analysis	  to	  
visualize	  the	  antibiotic	  profiles	  for	  these	  countries.	  Countries	  that	  included	  hospital	  
consumption	  in	  their	  reporting	  (Cyprus,	  Iceland,	  Lithuania	  and	  Slovakia),	  and	  countries	  that	  
reported	  parts	  of	  the	  national	  community	  consumption	  (Romania	  and	  Spain)	  were	  excluded	  
from	  the	  analysis	  as	  their	  antibiotic	  profiles	  were	  assumed	  to	  differ	  due	  to	  sampling	  design.	  
The	  weighted	  averages	  (centroids)	  of	  antibiotic	  profiles	  for	  each	  country	  were	  plotted	  
alongside	  antibiotic	  types	  in	  a	  biplot.	  	  
The	  countries	  with	  the	  lowest	  consumption	  (smallest	  filled	  circles)	  had	  a	  higher	  relative	  
consumption	  of	  other	  antibiotics	  (J01X),	  tetracyclines	  (J01A)	  and	  trimethoprim	  combinations	  
(J01E).	  Greece	  and	  Malta	  had	  a	  high	  relative	  consumption	  of	  other	  betalactam	  antibacterials	  
(Cephalosporins	  (J01D))	  and	  the	  ATC-­‐groups	  J01	  B,	  R	  or	  G.	  Belgium,	  Portugal,	  Denmark	  and	  
Slovenia	  had	  high	  relative	  consumptions	  of	  penicillins	  (J01C).	  Finally,	  Germany	  had	  the	  lowest	  
relative	  consumption	  of	  penicillins.	  
	  
Biplot	  of	  CA	  results	  for	  data	  from	  table	  3.1	  in	  Surveillance	  of	  antimicrobial	  consumption	  in	  Europe	  2011	  authored	  
by	  the	  ECDC.	  The	  biplot	  captures	  72%	  of	  the	  total	  variation	  of	  the	  data.	  Black	  filled	  circles	  represent	  the	  centroids	  
for	  each	  country.	  The	  size	  of	  each	  filled	  circle	  reflects	  relative	  total	  consumption.	  Red	  triangles	  indicate	  the	  
different	  antibiotic	  groups.	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Surveillance	  of	  antibiotic	  consumption	  
The	  European	  Surveillance	  of	  Antimicrobial	  Consumption	  Network	  (ESAC-­‐Net)	  
covers	  29	  European	  countries	  including	  Norway.	  Twelve	  quality	  indicators	  are	  
used	  to	  assess	  antibiotic	  consumption.	  Among	  these	  we	  find	  DID	  for	  several	  
classes	  of	  antibiotics,	  percentages	  of	  total	  consumption	  for	  ATC-­‐J01	  sub	  groups	  
and	  ratio	  of	  broad-­‐spectrum	  antibiotics	  versus	  narrow	  spectrum	  antibiotics.24	  	  
In	  the	  United	  States	  (US),	  as	  in	  most	  EU	  countries,	  there	  is	  no	  national	  or	  federal	  
prescription	  database.	  However,	  claims	  databases	  from	  insurance	  companies,	  
and	  the	  Medicaid	  database	  contains	  prescription	  data	  on	  the	  individual	  level.	  The	  
Medicaid	  database	  includes	  19%	  of	  the	  US	  population,	  but	  has	  limitations	  
especially	  with	  regards	  to	  bias	  in	  patient	  demographics.25	  
In	  1994	  Finland	  and	  Denmark	  established	  registries	  for	  prescriptions,	  and	  from	  
2006	  all	  Nordic	  countries	  (Finland,	  Denmark,	  Norway,	  Sweden	  and	  Iceland)	  have	  
a	  national	  prescription	  database.	  None	  of	  the	  databases	  includes	  hospital	  use	  or	  
indication	  of	  disease.26	  A	  recent	  review	  summarized	  the	  research	  based	  on	  the	  
Nordic	  prescription	  databases.	  Danish	  studies	  were	  most	  prevalent	  (51%	  of	  the	  
studies	  examined).	  Only	  a	  minor	  part	  of	  the	  studies	  (6%)	  addressed	  antibiotics.27	  	  
In	  Norway	  several	  sources	  of	  antibiotic	  consumption	  are	  available.	  	  At	  the	  
population	  level,	  wholesale	  statistics	  exists	  from	  1974	  until	  2013,	  and	  the	  total	  
sales	  from	  all	  classes	  of	  drugs	  are	  reported	  annually	  from	  the	  Norwegian	  
2
In	  Europe	  the	  countries	  with	  the	  lowest	  consumption	  measured	  in	  DID	  are	  associated	  with	  a	  
low	  consumption	  of	  penicillins.	  Of	  the	  countries	  with	  the	  highest	  consumption	  some	  are	  
related	  to	  a	  high	  penicillin	  use,	  whereas	  other	  are	  related	  to	  macrolides,	  other	  beta-­‐lactams	  
or	  other	  ATC-­‐	  J01	  groups.	  
	  
[1]	  European	  center	  for	  disease	  prevention	  and	  control.	  Surveillance	  of	  antimicrobial	  
consumption	  in	  Europe	  2011.	  Stockholm:	  ECDC;	  2014.	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institute	  of	  public	  health.28	  These	  data	  are	  only	  suited	  for	  ecological	  studies,	  as	  
no	  individual	  patient	  information	  is	  available.	  
The	  Norwegian	  Prescription	  Database	  (NorPD)	  was	  established	  in	  2004.	  All	  
Norwegian	  prescriptions	  are	  registered	  and	  are	  available	  for	  research	  with	  an	  
identifier	  for	  patient	  and	  prescriber.	  Further,	  aggregated	  data	  are	  publically	  
available	  through	  online	  resources.29,	  30Indication	  of	  disease	  is	  not	  routinely	  
collected	  for	  prescriptions,	  and	  assessment	  of	  appropriateness	  of	  prescribing	  is	  
difficult.	  It	  is	  not	  reasonable	  to	  assume	  a	  uniform	  distribution	  of	  infectious	  
diseases	  between	  genders	  or	  age	  classes	  of	  any	  population.	  This	  is	  illustrated	  in	  
differences	  in	  antibiotic	  consumption	  in	  age	  groups	  and	  genders	  in	  Norway.20	  
Therefore,	  causal	  inferences	  from	  available	  demographic	  variables	  in	  NorPD	  are	  
hampered	  with	  possible	  bias	  in	  prevalence	  of	  disease.	  	  
Population	  surveys	  can	  be	  used	  to	  investigate	  individual	  patients	  and	  their	  
consumption	  of	  antibiotics.	  In	  Norway,	  studies	  have	  been	  conducted	  on	  
respiratory	  tract	  infections	  where	  prescriber	  and	  patient	  information	  has	  been	  
combined	  with	  type	  of	  antibiotic	  and	  indication	  of	  disease.	  Population	  studies	  in	  
Tromsø	  and	  Bergen	  have	  used	  questionnaires	  to	  collect	  data	  on	  drug	  
consumption	  including	  antibiotic	  use.31-­‐34	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Predictors	  of	  antibiotic	  consumption	  
National	  guidelines	  are	  developed	  to	  aid	  prescribers	  in	  choice	  of	  antibiotic	  
therapy.35,	  36	  The	  indication	  and	  the	  pathogen	  in	  question	  are	  decisive	  of	  which	  
drug	  is	  optimal	  for	  treatment.	  Pathogen	  characteristics	  that	  influence	  the	  choice	  
of	  antibiotic	  include	  whether	  the	  bacteria	  are	  gram-­‐negative	  or	  positive	  and	  
known	  resistance	  issues.35	  	  
However,	  variables	  related	  to	  both	  prescriber	  and	  patient	  also	  affect	  treatment.	  
In	  a	  study	  including	  17	  European	  countries,	  the	  authors	  found	  no	  association	  
between	  morbidity	  caused	  by	  infectious	  diseases	  and	  overall	  consumption	  of	  
antibiotics.	  In	  this	  study	  the	  authors	  adjusted	  for	  socioeconomic,	  demographic	  
and	  supply	  variables	  in	  their	  analysis.37	  Consequently,	  other	  variables,	  besides	  
indication	  of	  disease,	  can	  affect	  the	  amount	  and	  type	  of	  antibiotics	  prescribed.38	  
A	  study	  comparing	  antibiotic	  prescribing	  in	  Germany	  and	  France	  addresses	  five	  
non-­‐microbiological	  factors	  influencing	  the	  use	  of	  antibiotics;	  prescriber	  factors,	  
patient	  factors,	  cultural	  influences,	  social	  determinants	  and	  regulatory	  
practices.39	  The	  authors	  conclude	  that	  France	  has	  a	  higher	  antibiotic	  prescribing	  
rate,	  especially	  for	  upper	  respiratory	  tract	  infections.	  The	  authors	  attribute	  these	  
differences	  to	  prescriber	  and	  patient	  attitudes	  in	  addition	  to	  sociocultural	  and	  
economic	  differences.	  	  	  
In	  this	  thesis	  I	  will	  focus	  on	  three	  predictors	  of	  outpatient	  antibiotic	  use:	  Patient,	  
prescriber	  and	  geography.	  Improved	  understanding	  of	  the	  contribution	  from	  
these	  predictors	  is	  important	  to	  identify	  possible	  differences	  in	  selection	  
pressure	  on	  bacteria,	  and	  to	  address	  areas	  or	  demographic	  groups	  with	  a	  specific	  
antibiotic	  consumption	  pattern.	  Paper	  I	  addresses	  demographic	  groups	  of	  
prescribers	  and	  patients,	  Paper	  II	  addresses	  regional	  differences	  and	  finally	  
Paper	  III	  addresses	  how	  heterogenic	  antibiotic	  pulses	  affect	  resistance	  
determinants	  in	  bacteria.	  
Patient	  
Patient	  age	  and	  gender,	  income,	  education	  and	  cultural	  differences	  are	  variables	  
that	  influence	  antibiotic	  prescriptions.20,	  37,	  40	  A	  previous	  Norwegian	  study	  
showed	  that	  female	  patients	  had	  a	  higher	  one-­‐year	  prevalence	  of	  antibiotic	  use	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than	  males	  (except	  children	  below	  8	  years).	  There	  was	  also	  a	  difference	  in	  
antibiotic	  profiles	  between	  age	  groups	  and	  gender.	  Females	  used	  more	  broad-­‐
spectrum	  penicillins	  than	  males,	  and	  males	  had	  relatively	  higher	  tetracycline	  
consumption	  compared	  to	  females.	  Finally,	  high	  users	  where	  found	  to	  be	  among	  
adolescents	  (predominantly	  males)	  and	  the	  elderly	  (no	  gender	  difference).20	  In	  
Italy	  the	  prevalence	  of	  antibiotic	  prescription	  showed	  similar	  patterns	  as	  in	  
Norway,	  however	  the	  overall	  prevalence	  was	  higher	  in	  the	  Italian	  study.41	  
Recently	  it	  has	  been	  demonstrated	  that	  antibiotic	  consumption	  increases	  with	  
age	  among	  French	  outpatients.42	  Females	  where	  also	  found	  to	  have	  higher	  odds	  
for	  receiving	  a	  prescription	  of	  an	  antibiotic	  compared	  to	  males.43	  Further,	  when	  
adjusting	  for	  type	  of	  infection,	  patients	  over	  45	  years	  had	  lower	  odds	  of	  being	  
prescribed	  antibiotics.	  
Socioeconomic	  factors	  such	  as	  the	  proportion	  of	  women	  working	  and	  the	  
proportion	  of	  the	  population	  with	  higher	  education	  have	  been	  reported	  to	  
reduce	  antibiotic	  consumption.	  However,	  the	  results	  depend	  on	  the	  statistical	  
model	  chosen.37	  An	  Australian	  study	  investigated	  the	  effect	  of	  patient	  
expectations	  on	  the	  odds	  for	  being	  prescribed	  a	  new	  medication.	  This	  study	  was	  
inconclusive,	  as	  patients	  who	  expected	  a	  new	  medication	  and	  patients	  that	  had	  
no	  opinion	  both	  had	  higher	  odds	  of	  receiving	  treatment	  than	  patients	  that	  did	  
not	  expect	  a	  prescription.	  If	  the	  prescriber	  believed	  the	  patient	  wanted	  a	  new	  
prescription	  the	  odds	  increased	  10-­‐fold	  for	  receiving	  a	  prescription.44	  In	  Spain	  a	  
study	  found	  that	  prescribers	  overestimate	  the	  patients	  expectations	  for	  receiving	  
a	  prescription,	  and	  prescribe	  more	  often	  than	  their	  patients	  expected.45	  German	  
investigators	  found	  that	  only	  10%	  of	  patients	  visiting	  a	  physician	  for	  the	  
common	  cold	  anticipated	  a	  prescription	  of	  antibiotics.	  These	  authors	  also	  
suggest	  that	  physicians	  overestimate	  the	  expectations	  patients	  have	  for	  receiving	  
antibiotic	  prescriptions.46	  
Prescriber	  
When	  treating	  respiratory	  tract	  infections	  in	  children,	  General	  Practitioner	  (GP)	  
specialists	  in	  Norway	  had	  lower	  odds	  of	  prescribing	  an	  antibiotic	  than	  non-­‐
specialists.	  Age	  of	  the	  prescriber	  did	  not	  influence	  the	  odds	  of	  prescribing	  an	  
antibiotic	  when	  both	  age	  and	  speciality	  was	  included	  in	  a	  logistic	  regression	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model.	  However,	  in	  the	  same	  study	  specialists	  had	  higher	  odds	  of	  prescribing	  
non-­‐penicillin	  V	  antibiotics.47	  In	  the	  UK,	  prescriber	  age	  above	  45	  years	  increased	  
the	  amount	  of	  prescribed	  antibiotics.48	  However,	  years	  in	  practice	  was	  not	  a	  
significant	  predictor	  of	  increased	  antibiotic	  prescribing	  in	  a	  study	  from	  Ireland.49	  
In	  Italy,	  time	  since	  certification	  was	  found	  to	  lower	  the	  odds	  for	  prescribing	  an	  
antibiotic.43	  In	  Belgium,	  middle-­‐aged	  prescribers	  had	  higher	  odds	  of	  prescribing	  
broad-­‐spectrum	  antibiotics	  than	  both	  younger	  and	  older	  prescribers.50	  Time	  in	  
practice	  has	  also	  been	  found	  to	  increase	  the	  probability	  for	  inappropriate	  
antibiotic	  prescribing	  as	  well	  as	  being	  a	  predictor	  of	  high	  prescribers	  in	  both	  USA	  
and	  Canada.51,	  52	  	  
Studies	  investigating	  prescriber	  gender	  are	  inconclusive	  whether	  and	  how	  
gender	  affects	  prescribing.	  Prescriber	  gender	  can	  increase	  odds	  of	  prescribing	  an	  
antibiotic,	  selecting	  broad-­‐spectrum	  alternatives	  and	  also	  being	  a	  high	  antibiotic	  
prescriber.	  Female	  prescribers	  are	  associated	  with	  lower	  odds	  of	  prescribing	  an	  
antibiotic.43	  The	  aforementioned	  UK	  study	  found	  higher	  amounts	  prescribed	  by	  
male	  GP’s.48	  Recently,	  investigators	  also	  found	  females	  to	  have	  higher	  odds	  of	  
prescribing	  amoxicillin	  over	  broader	  spectrum	  alternatives	  for	  both	  adults	  and	  
children,	  although	  effect	  sizes	  where	  small	  for	  adults.50	  Norwegian	  studies,	  and	  a	  
US	  study	  report	  no	  differences	  between	  prescriber	  genders.32,	  33,	  47,	  51,	  53	  
Prescriber	  age	  is	  addressed	  in	  a	  variety	  of	  ways	  across	  studies.	  Some	  studies	  use	  
age	  directly,	  other	  use	  time	  since	  medical	  exam	  or	  simply	  the	  dichotomous	  
version:	  specialist	  (presumably	  older)	  and	  non-­‐specialist.	  Consequently,	  studies	  
addressing	  antibiotic	  prescribing	  and	  prescriber	  age	  display	  conflicting	  results.	  	  
Attitudes	  towards	  antibiotic	  prescriptions	  for	  respiratory	  infections	  among	  
German	  and	  French	  prescribers	  differ,	  where	  the	  German	  prescribers	  are	  more	  
restrictive	  in	  their	  use	  of	  antibiotics	  compared	  to	  the	  French.39	  A	  survey	  from	  
Wales	  found	  that	  the	  patient’s	  clinical	  characteristics	  were	  important	  for	  
prescribers	  in	  choice	  of	  antibiotics,	  as	  did	  information	  on	  the	  pathogen	  in	  
question.54	  The	  authors	  also	  dichotomised	  prescribers	  with	  regard	  to	  their	  
socially	  responsible	  prescribing	  practice;	  those	  taking	  care	  of	  the	  individual	  
patient	  immediately	  (higher	  fluoroquinolone	  use),	  or	  those	  who	  try	  narrow	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spectrum	  choices	  to	  prevent	  future	  resistance	  problems	  (lower	  fluoroquinolone	  
use).	  
Geography	  
Where	  patients	  live	  influences	  both	  probabilities	  of	  receiving	  antibiotics,	  type	  
received	  and	  amount	  of	  antibiotics	  prescribed.	  	  Geographical	  entities	  are	  in	  
themselves	  hardly	  the	  cause	  of	  differences	  in	  antibiotic	  consumption,	  but	  a	  proxy	  
for	  other,	  unmeasured	  variables.	  For	  instance	  differences	  in	  prevalence	  of	  
infectious	  diseases,	  doctors	  per	  thousand	  inhabitants,	  income,	  ease	  of	  access	  to	  
healthcare	  services,	  over	  the	  counter	  sales	  of	  antibiotics,	  mortality	  rate	  and	  other	  
demographic	  variables	  can	  influence	  geographical	  variation.55	  	  
Several	  authors	  have	  studied	  variation	  in	  antibiotic	  consumption	  between	  
countries15,	  37,	  56-­‐60	  or	  regional	  differences	  within	  a	  country.40,	  41,	  61-­‐69	  An	  
investigation	  from	  Germany	  finds	  regional	  variation,	  however	  none	  of	  the	  
investigated	  variables	  predict	  the	  observed	  differences.67	  Later	  attempts,	  with	  
different	  aggregation	  levels,	  finds	  areal	  deprivation	  as	  a	  predictor	  of	  regional	  
variation	  in	  Germany.65	  Amount	  of	  antibiotics	  consumed	  (measured	  in	  DID),	  both	  
overall	  and	  for	  specific	  classes	  was	  compared	  between	  different	  regions	  in	  
Switzerland.	  The	  investigators	  found	  differences	  between	  regions,	  the	  highest	  
consuming	  region	  had	  1.5	  times	  the	  overall	  antibiotic	  consumption	  of	  north-­‐
western	  Switzerland.70	  Consumption	  of	  antibiotics	  are	  higher	  during	  winter,	  and	  
regions	  with	  a	  high	  consumption	  demonstrate	  higher	  seasonal	  fluctuations	  than	  
lower	  consuming	  regions.57,	  70	  It	  has	  been	  shown	  that	  fluctuations	  in	  antibiotic	  
use	  coincide	  with	  influenza	  epidemics,	  leading	  to	  an	  increased	  consumption	  of	  
fluoroquinolones.	  Although	  secondary	  infection	  of	  bacteria	  is	  possible	  during	  
influenza	  outbreaks,	  increased	  quinolone	  use	  indicates	  that	  pathogens	  other	  
than	  bacteria	  can	  influence	  the	  (mis)	  use	  of	  antibiotics.71	  
	  
Differences	  between	  countries	  are	  often	  large,	  both	  with	  respect	  to	  type	  and	  
amount	  of	  antibiotics	  prescribed.	  A	  recent	  comparison	  of	  non	  European	  Union	  
countries	  shows	  a	  nearly	  threefold	  difference	  in	  DID	  between	  low	  and	  high	  
consuming	  countries.	  In	  2011	  Turkey	  had	  a	  total	  antibiotic	  consumption	  of	  42.3	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DID,	  in	  comparison	  Norwegian	  total	  consumption	  was	  20.6	  DID	  (17.2	  DID	  
methenamine	  omitted).56,	  72	  
Summary	  
Evidently,	  patient,	  prescriber	  and	  geography	  are	  not	  variables	  influencing	  
antibiotic	  consumption	  in	  isolation.	  These	  variables	  are	  often	  considered	  in	  
combination	  and	  seem	  to	  interact.	  Due	  to	  differences	  in	  choices	  of	  explanatory	  
and	  outcome	  variables	  among	  the	  aforementioned	  studies	  a	  direct	  comparison	  is	  
highly	  challenging	  and	  certainly	  not	  straightforward.	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Variety	  of	  methods	  in	  pharmacoepidemiology	  
During	  literature	  search	  for	  Paper	  I	  and	  II	  and	  the	  current	  thesis	  we	  identified	  34	  
papers	  investigating	  antibiotic	  consumption	  at	  the	  ecological	  level	  using	  multiple	  
regression	  (linear,	  logistic	  or	  others).	  The	  papers	  were	  published	  between	  1999	  
and	  2014	  in	  23	  different	  journals.10,	  11,	  32,	  33,	  37,	  40,	  41,	  43,	  47,	  48,	  50,	  53,	  57,	  59,	  62,	  65,	  66,	  68,	  70,	  
73-­‐87	  
Twenty	  of	  the	  above	  mentioned	  papers	  compared	  different	  regression	  models.	  
The	  papers	  not	  considering	  model	  selection	  in	  the	  text	  used	  either	  p-­‐values	  or	  p-­‐
values	  in	  combination	  with	  other	  diagnostic	  tools	  (for	  instance	  R2)	  for	  statistical	  
inference.	  The	  methods	  of	  model	  selection	  of	  the	  20	  papers	  are	  summarized	  in	  
Figure	  1.	  P-­‐value	  interpretation	  is	  central	  to	  13	  of	  the	  studies.	  Studies	  relying	  
only	  on	  p-­‐values	  (n=5)	  typically	  use	  either	  a	  back-­‐	  or	  forward	  step-­‐wise	  selection	  
procedure.	  Some	  studies	  (n=4)	  combine	  p-­‐values	  with	  R2	  values	  (or	  pseudo	  R2),	  
and	  a	  category	  of	  others	  are	  constructed	  to	  cover	  tests	  as	  likelihood	  ratio	  test	  
and	  the	  Wald	  test	  (7	  studies).	  
None	  of	  the	  papers	  used	  information	  criteria,	  such	  as	  Akaike’s	  Information	  
Criterion	  (AIC),	  for	  model	  selection.	  None	  of	  the	  papers	  considered	  Directed	  
Acyclic	  Graphs	  (DAG)	  for	  identification	  of	  confounders.	  These	  methods	  are	  used	  
and	  described	  in	  further	  details,	  in	  Paper	  II	  and	  in	  the	  discussion	  of	  the	  thesis.	  
Five	  papers	  were	  considered	  to	  have	  efficient	  methods	  for	  model	  selection,	  and	  
avoided	  using	  only	  p-­‐values	  and	  R2	  as	  selection	  criteria.	  Typically	  these	  papers	  
used	  multilevel	  models	  and	  tests	  based	  on	  the	  likelihood	  function.	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Figure	  1	  Venn	  diagram	  of	  the	  distribution	  of	  model	  selection	  techniques	  from	  20	  
papers	  conducting	  multivariable	  regression	  addressing	  different	  aspects	  of	  
antibiotic	  consumption	  and	  resistance.	  Studies	  only	  using	  p-­‐values	  rely	  on	  
stepwise	  backward	  elimination	  or	  forward	  selection.	  R2	  values	  are	  used	  to	  
explain	  how	  much	  of	  the	  variation	  in	  the	  dataset	  the	  model	  explains.	  Other	  
selection	  techniques	  include	  tests	  like	  likelihood	  ratio	  and	  the	  Wald	  test.	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Summary	  
Studies	  on	  antibiotic	  consumption	  that	  include	  patient,	  prescriber	  and	  
geographical	  variables	  are	  not	  conclusive.	  Model	  selection	  procedures	  in	  
pharmacoepidemiology	  are	  frequently	  sub-­‐optimal.	  In	  order	  to	  efficiently	  
address	  the	  predictors	  patient,	  prescriber	  and	  geography	  several	  statistical	  
methods	  are	  available,	  and	  methodology	  is	  under	  constant	  development.	  
Implementation	  of	  DAG	  and	  AIC	  into	  studies	  concerning	  antibiotic	  consumption	  
will	  strengthen	  analysis,	  and	  possibly	  lead	  to	  studies	  that	  are	  more	  uniform	  in	  
their	  conclusions.	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Antibiotic	  consumption	  and	  resistance	  in	  bacteria	  
Bacteria	  have	  accumulated	  a	  broad	  range	  of	  genetic	  traits	  encoding	  resistance	  
against	  a	  multitude	  of	  antibiotics,	  and	  these	  traits	  are	  found	  worldwide.6,	  88-­‐90	  
The	  problem	  of	  resistant	  bacteria	  has	  been	  known	  for	  decades,	  91	  and	  genome	  
analyses	  show	  that	  changes	  in	  bacterial	  genomes	  coincide	  temporally	  with	  an	  
increasing	  use	  of	  antibiotics	  for	  humans	  and	  livestock.92-­‐94	  	  
Bacteria	  resistant	  towards	  antibiotics	  are	  by	  no	  means	  restricted	  to	  hospitals,	  
agricultural	  areas	  or	  aquaculture	  where	  antibiotic	  use	  is	  frequent,	  but	  are	  also	  
found	  in	  pristine	  environments.8,	  9,	  92,	  94,	  95	  
Types	  of	  resistance	  
Intrinsic	  
Already	  at	  the	  time	  of	  penicillin	  discovery	  it	  was	  reported	  that	  bacteria	  varied	  in	  
their	  susceptibility.96	  Some	  bacteria	  are	  multidrug	  resistant	  through	  natural	  cell	  
functions.	  Efflux	  pumps,	  which	  reduce	  the	  concentration	  of	  antibiotics	  within	  the	  
cell,	  typically	  mediate	  this	  resistance.	  These	  efflux	  pumps	  can	  be	  targeted	  
towards	  specific	  compounds	  or	  multiple	  drugs.97	  Simultaneously	  the	  protective	  
layer	  provided	  by	  the	  membrane	  of	  bacteria	  act	  alone	  or	  synergistically	  with	  the	  
effects	  of	  efflux	  pumps.	  For	  instance	  gram-­‐negative	  bacteria	  have	  a	  higher	  degree	  
of	  protection	  due	  to	  the	  outer	  membrane.	  In	  addition	  to	  these	  mechanisms	  basic	  
cellular	  functions	  in	  bacteria	  can	  aid	  in	  resisting	  antibiotics.	  Intrinsic	  resistance	  
is	  usually	  not	  considered	  to	  be	  a	  function	  that	  is	  easily	  transferred	  between	  
bacteria.98	  
Acquired	  
Bacteria	  acquire	  resistance	  genes	  either	  through	  mutations	  or	  transfer	  of	  genetic	  
information	  by	  Horizontal	  Gene	  Transfer	  (HGT).99	  
Mutations	  
Mutations	  in	  bacteria	  can	  render	  them	  less	  sensitive	  towards	  antibiotics.	  
Alteration	  of	  drug	  targets	  and	  modification	  of	  efflux	  pumps	  are	  examples	  of	  
resistance	  due	  to	  mutations	  in	  protein	  coding	  genes.99	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Horizontal	  gene	  transfer	  
Bacteria	  exchange	  genes,	  even	  crossing	  the	  genus	  level,	  by	  a	  multitude	  of	  
pathways.3,	  99,	  100	  HGT	  allows	  bacteria	  to	  rapidly	  acquire	  complex	  genetic	  changes	  
compared	  to	  the	  slower	  process	  of	  mutations.101	  Resistance	  towards	  single	  or	  
multiple	  compounds	  can	  be	  acquired	  in	  a	  single	  step,	  letting	  bacteria	  take	  
evolutionary	  leaps.	  The	  success	  of	  HGT	  elements	  in	  a	  bacterial	  population	  (or	  in	  
ecosystems)	  is	  dependent	  not	  only	  on	  the	  mechanism	  of	  dispersal,	  but	  also	  on	  
the	  fitness	  advantage	  for	  the	  receiving	  bacteria.102	  
HGT	  is	  a	  topic	  of	  great	  interest	  in	  scientific	  literature	  and	  excellent	  reviews	  have	  
been	  published	  in	  top	  ranking	  journals.	  Three	  of	  these	  form	  the	  basis	  for	  the	  
following	  brief	  overview.102-­‐105	  	  
Three	  modes	  of	  horizontal	  gene	  transfer	  
Natural	  transformation	  is	  the	  process	  of	  uptake	  and	  integration	  of	  exogenous	  
DNA.103	  Although	  the	  mechanisms	  for	  uptake	  differ	  between	  gram	  positive	  and	  
gram	  negative	  bacteria,	  the	  processes	  are	  similar.103,	  106	  The	  DNA	  may	  originate	  
from	  destroyed	  cells,	  phages	  or	  active	  excretions	  of	  genetic	  material	  and	  can	  be	  
found	  inside	  bacterial	  hosts	  (in	  faeces,	  blood	  saliva	  etc.),	  or	  in	  external	  
environments	  such	  as	  soil,	  or	  in	  water.102	  It	  has	  been	  demonstrated	  that	  bacteria	  
also	  can	  use	  fragmented,	  damaged,	  and	  even	  ancient	  non-­‐bacterial	  DNA.107	  
During	  natural	  transformation	  the	  competent	  bacteria	  taking	  up	  the	  DNA	  is	  the	  
active	  part,	  in	  contrast	  to	  conjugation	  and	  transduction	  where	  the	  receiving	  cell	  
is	  (more)	  passive.102	  	  
Conjugation	  occurs	  when	  bacteria	  transfer	  DNA	  (plasmid	  or	  integrated	  
conjugative	  elements)	  with	  cell	  interactions	  and	  is	  dependent	  on	  physical	  
contact.104	  Two	  bacterial	  cells	  connect	  through	  a	  pilus.103	  Although	  other	  modes	  
of	  plasmid	  transport	  between	  cells	  exist,	  conjugation	  is	  most	  common.	  The	  
receiving	  cell	  can	  have	  some	  degree	  of	  protection	  against	  plasmid	  transfer	  
through	  exclusion	  at	  the	  surface	  and	  restriction	  enzymes.102	  	  
As	  plasmids	  were	  common	  in	  bacteria	  prior	  to	  widespread	  antibiotic	  use,	  it	  is	  
possible	  that	  human	  antibiotic	  use	  has	  led	  to	  resistance	  determinants	  being	  
acquired	  by	  pre-­‐existing	  plasmids.108,	  109	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Transduction	  is	  transfer	  of	  bacterial	  DNA	  through	  a	  bacteriophage.	  Phages	  can	  
incorporate	  host	  (bacterial)	  DNA	  and	  transfer	  it	  as	  double	  stranded	  DNA.	  This	  
process	  is	  independent	  of	  contact	  between	  donor	  and	  recipient.	  However,	  this	  
form	  of	  transfer	  is	  mostly	  limited	  to	  related	  species	  as	  bacteriophages	  normally	  
have	  relatively	  narrow	  host	  ranges.104	  	  
Inter-­‐	  and	  intracellular	  transport	  of	  genetic	  elements	  
While	  bacteriophages,	  plasmids	  and	  other	  Mobile	  Genetic	  Elements	  (MGE)	  are	  
spreading	  intercellularly,	  there	  are	  MGEs	  that	  are	  spreading	  intracellularly	  and	  
are	  transported	  between	  cells	  by	  the	  aid	  of	  an	  intercellular	  MGE.104,	  105	  
Integrons	  are	  intracellular	  genetic	  elements	  that	  have	  the	  ability	  to	  acquire	  gene	  
cassettes	  and	  possess	  a	  system	  to	  express	  these	  genes	  (promoter).	  	  Gene	  
cassettes	  are	  small	  genetic	  segments	  that	  are	  integrated	  and	  transcribed	  within	  
the	  content	  of	  integrons.110	  Integrons	  rely	  on	  intercellular	  MGE	  (for	  instance	  a	  
plasmid)	  to	  facilitate	  transport	  between	  cells	  and	  on	  transposons	  for	  
intracellular	  mobilization	  (between	  genome	  and	  plasmid).105	  A	  visualization	  of	  
plasmid	  and	  transposon	  mediated	  integron	  mobilization	  within	  and	  between	  
cells	  is	  displayed	  in	  Figure	  2.	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Figure	  2	  Overview	  of	  plasmid	  and	  transposon	  mediated	  mobilization	  of	  
integrons.	  Integrons	  possess	  the	  ability	  to	  capture	  (and	  express)	  gene	  cassettes.	  
When	  integrated	  in	  a	  transposon	  the	  integron	  can	  relocate	  between	  the	  
chromosome	  and	  plasmids.	  The	  plasmid	  can	  be	  transferred	  to	  a	  new	  cell	  where	  
the	  integron	  either	  can	  remain	  on	  the	  plasmid	  and	  express	  incorporated	  gene	  
cassettes	  or,	  through	  the	  transposon,	  relocate	  to	  other	  parts	  of	  the	  genome.	  MGE	  
(transposons	  and	  plasmids)	  connected	  to	  a	  integron	  are	  coloured	  in	  light	  blue,	  
transport	  between	  cells	  in	  red,	  dotted	  lines	  represents	  possibilities	  of	  gene	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While	  natural	  transformation,	  conjugation	  and	  transduction	  are	  the	  classical	  
modes	  of	  HGT	  other	  mechanisms	  exist.	  Outer	  membrane	  vesicles	  have	  the	  ability	  
to	  transfer	  DNA	  in	  Acinetobacter	  baylyi.	  Other	  structures	  called	  nanotubes	  have	  
been	  demonstrated	  to	  facilitate	  transport	  of	  plasmids.111,	  112	  
The	  cost	  and	  reversal	  of	  resistance	  
Antibiotics	  act	  as	  selective	  agents	  in	  three	  ways:	  First,	  they	  select	  for	  already	  
existing,	  naturally	  occurring	  resistant	  genotypes	  or	  spontaneous	  mutations.	  
Secondly,	  they	  can	  act	  as	  a	  mediator	  for	  bacterial	  heterogeneity	  by	  increasing	  
genetic	  variability	  and	  finally	  they	  can	  act	  as	  signalling	  molecules.113	  
Acquired	  antibiotic	  resistance	  often	  comes	  with	  a	  fitness	  cost	  for	  the	  bacteria.	  
This	  can	  be	  a	  cost	  of	  harbouring	  the	  gene	  itself,	  from	  a	  plasmid,	  or	  the	  fitness	  cost	  
of	  an	  integron,	  or	  combinations	  of	  these.	  The	  disadvantage	  of	  this	  cost	  is	  
counteracted	  by	  the	  presence	  of	  antibiotics.	  Antibiotics	  allow	  the	  resistant	  
bacteria	  to	  outcompete	  their	  susceptible	  counterparts,	  which	  suffer	  a	  fitness	  
reduction	  induced	  by	  the	  antibiotics.114,	  115	  	  
The	  concentration	  of	  an	  antibiotic	  that	  visually	  inhibits	  bacterial	  growth	  after	  
incubation	  is	  referred	  to	  as	  the	  Minimum	  Inhibitory	  Concentration	  (MIC).	  This	  
concentration	  is	  used	  to	  define	  bacteria	  as	  susceptible	  or	  resistant.116,	  117	  
However,	  selection	  of	  resistant	  bacteria	  starts	  at	  concentrations	  lower	  than	  the	  
MIC.	  Sub-­‐MIC	  concentrations	  allow	  bacteria	  to	  grow,	  but	  at	  a	  slower	  rate	  than	  in	  
antibiotic	  free	  environments,	  and	  can	  thereby	  act	  as	  a	  selective	  force	  promoting	  
resistant	  genotypes.113	  	  
A	  review	  on	  reversal	  of	  resistance	  highlights	  that	  reduced	  antibiotic	  
consumption	  does	  not	  always	  imply	  rapidly	  reduced	  prevalence	  of	  resistant	  
bacteria.115	  	  The	  authors	  present	  investigations	  where	  reduced	  levels	  of	  
resistance	  are	  found	  118,	  119	  alongside	  studies	  that	  demonstrate	  no	  effect.120	  	  One	  
study	  even	  found	  increased	  prevalence	  of	  antibiotic	  resistance	  after	  reduced	  
consumption.121	  Even	  if	  genetic	  elements	  encoding	  antibiotic	  resistance	  impose	  a	  
fitness	  cost	  bacteria	  harbouring	  these	  can	  still	  persist.	  Theoretical	  models	  and	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experimental	  evolution	  suggest	  that	  reduced	  fitness	  can	  be	  mitigated	  through	  
compensatory	  mutations	  (as	  opposed	  to	  reversal	  to	  non-­‐susceptibility),	  or	  
episodes	  of	  periodic	  selection.114,	  122,	  123	  We	  have	  addressed	  periodic	  selection	  
and	  fitness	  costs	  related	  to	  integrons	  in	  Paper	  III	  where	  we	  combined	  results	  
from	  evolutionary	  experiments	  with	  theoretical	  modelling	  to	  investigate	  
conditions	  that	  favour	  MGE’s	  harbouring	  antibiotic	  resistance	  determinants.	  
	  
Summary	  
Evidently,	  several	  factors	  affect	  antibiotic	  resistance.	  It	  is	  not	  the	  scope	  of	  the	  
presented	  work	  to	  cover	  all	  areas,	  but	  rather	  to	  put	  the	  presented	  papers	  into	  a	  
broader	  framework.	  Illustrating	  the	  general	  mechanisms	  affecting	  antibiotic	  
resistance	  demands	  a	  balance	  between	  the	  principle	  of	  parsimony	  and	  enough	  
details	  to	  encapsulate	  the	  known	  dynamics.	  Figure	  3	  summarizes	  factors	  
involved	  in	  the	  evolution,	  spread	  and	  persistence	  of	  antimicrobial	  resistance.	  
Each	  factor	  depicted	  in	  Figure	  3	  has	  a	  number	  of	  components	  or	  sub-­‐levels	  that	  
are	  omitted	  from	  display.	  The	  topics	  addressed	  by	  study	  I,	  II	  and	  III	  are	  
highlighted.	  Human	  outpatient	  antibiotic	  consumption,	  selective	  pressure	  from	  




	   	  
	   29	  
	  
Figure	  3	  Flowchart	  depicting	  how	  human	  activity	  and	  naturally	  occurring	  
phenomena	  affect	  the	  level	  of	  antibiotic	  resistance.	  The	  figure	  is	  based	  on	  a	  
number	  of	  references	  from	  reviews	  and	  original	  reports,	  mainly	  references	  6,	  15,	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Describe	  the	  antibiotic	  drug	  consumption	  in	  Norway,	  and	  address	  how	  
heterogenic	  antibiotic	  environments	  can	  favour	  bacterial	  resistance.	  
Paper	  I	  
Identify	  patterns	  in	  Norwegian	  antibiotic	  prescriptions	  and	  identify	  prescriber	  
and	  patient	  characteristics	  that	  are	  associated	  with	  specific	  antibiotic	  profiles	  
Paper	  II	  
Determine	  if	  regional	  differences	  in	  outpatient	  antibiotic	  prescriptions	  can	  be	  
explained	  by	  a	  south-­‐north	  axis	  at	  municipality	  and	  county	  level	  in	  Norway.	  
Paper	  III	  
Investigate	  to	  what	  extent	  horizontally	  acquired	  resistance	  traits	  pose	  a	  fitness	  
cost	  for	  bacteria,	  and	  how	  periodic	  selection	  can	  favour	  these	  resistance	  traits.	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Material	  and	  Methods	  
In	  the	  current	  work	  three	  analytical	  approaches	  were	  used.	  
First,	  a	  multivariate	  analysis	  was	  used	  to	  summarize	  prescription	  data	  and	  
identify	  patterns	  of	  consumption	  in	  the	  entire	  Norwegian	  population.	  	  
Secondly,	  quantile	  regression	  was	  used	  to	  investigate	  the	  effect	  of	  a	  south-­‐north	  
axis	  and	  population	  size	  at	  three	  different	  aggregation	  levels.	  For	  model	  selection	  
DAG	  and	  AIC	  were	  used.	  
Finally,	  we	  investigated	  periodic	  selections	  that	  favoured	  maintenance	  of	  an	  
acquired	  resistance	  determinant.	  This	  was	  done	  through	  a	  mathematical	  model	  
that	  was	  parameterized	  with	  data	  from	  laboratory	  experiments.	  	  
	  These	  methods	  are	  selected	  on	  the	  basis	  of	  the	  research	  question	  and	  the	  
structure	  of	  the	  data	  available.	  The	  methods	  and	  data	  sources	  are	  summarized	  in	  
Table	  1	  and	  presented	  in	  further	  detail	  below.	  
Computer	  software	  
Central	  to	  paper	  I	  through	  III	  is	  the	  software	  and	  computer	  language	  R.	  This	  
highly	  flexible	  computing	  environment	  has	  been	  used	  in	  several	  versions	  during	  
the	  projects,	  including	  additional	  packages.	  R	  version	  3.0.3	  “Warm	  Puppy”	  is	  the	  
latest	  addition	  being	  used.127	  	  Further	  packages	  such	  as	  “Vegan”,	  “quantreg”,	  
“deSolve”,	  “rgl”,	  “diagram”	  and	  “VennDiagram”	  have	  been	  essential	  tools	  to	  solve	  
the	  different	  analytical	  tasks	  and	  graphical	  presentations.128-­‐133	  Besides	  R,	  SPSS	  
has	  been	  used,	  mainly	  for	  organizing	  data,	  and	  finally	  the	  online	  tool	  DAGitty	  was	  
used	  for	  construction	  of	  the	  DAG	  model	  used.134,	  135	  
Data	  sources	  
Papers	  I	  and	  II	  are	  based	  on	  data	  from	  NorPD.	  This	  database	  is	  a	  compulsory	  
registry	  where	  all	  dispensed	  prescriptions	  in	  Norway	  are	  registered	  with	  
information	  on	  patient,	  prescriber,	  type	  of	  prescription,	  type	  of	  drug,	  amount	  of	  
drug,	  the	  pharmacy	  and	  date.29,	  30	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Variables	  used	  
In	  Papers	  I	  and	  II	  variables	  from	  NorPD	  are	  combined	  with	  official	  statistics	  on	  
Norwegian	  demographics	  (provided	  by	  Statistics	  Norway)	  and	  an	  open	  source	  
database	  on	  geographical	  locations	  of	  administrative	  centres	  in	  Norway.136,	  137	  	  
We	  used	  data	  from	  2004	  until	  2010	  and	  included	  all	  prescriptions	  from	  ATC	  
class	  J	  01.	  In	  accordance	  with	  previous	  studies,	  we	  excluded	  methenamine	  from	  
the	  analysis.20	  Patient	  age,	  gender,	  municipality	  of	  residence,	  prescriber	  age,	  
prescriber	  gender	  and	  type	  and	  amount	  of	  drug	  dispensed	  were	  used	  in	  the	  two	  
studies.	  For	  a	  detailed	  overview	  see	  Table	  1	  and	  Papers	  I	  and	  II.	  In	  Paper	  III	  we	  
used	  data	  from	  laboratory	  experiments	  (measures	  of	  relative	  fitness)	  and	  
existing	  literature	  to	  parameterize	  a	  mathematical	  model.	  We	  simulated	  
antibiotic	  pulses	  at	  different	  time	  intervals	  and	  presented	  median	  simulation	  
results.	  ANOVA	  with	  post	  hoc	  t-­‐test	  with	  Bonferroni	  corrections	  were	  used	  to	  
measure	  difference	  in	  relative	  fitness	  between	  experimental	  groups	  of	  bacteria.
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Table	  1	  Overview	  over	  statistical	  methods,	  data	  sources	  and	  variables	  used	  in	  Papers	  I	  -­‐	  III	  
	   	   Methods	   Origin	  of	  Data	   Outcome	  variables	   Explanatory	  variables	  




DID	  for	  8	  antibiotic	  groups¤	   Age*	  and	  gender	   Patient	  and	  
prescriber	  
Type¤,	  amount	  and	  year	   Prescription	  
Study	  2	   Multivariable	  regression	  
Quantile	  regression,	  directed	  






Aggregated	  DID	  for	  all	  
antibiotics	  at	  three	  different	  
aggregation	  levels,	  data	  
where	  age	  adjusted	  
Residence	  and	  ageu	   Patient	  
Amount	  and	  year	   Prescription	  
Location	  and	  population	  size	   Geographical	  
units	  
Study	  3	   Mathematical	  modelling	  
Differential	  equations	  
Anova	  /	  t-­‐test	  	  
Simulations	  
Laboratory	  experiments	  
Results	  from	  simulations	  
Relative	  fitness	  of	  bacterial	  
populations	  
Experimental	  treatment	  
*Age	  was	  estimated	  by	  subtracting	  year	  of	  birth	  from	  year	  of	  dispensing.	  	  
¤ATC	  codes	  were	  used	  to	  aggregate	  antibiotics	  into	  8	  groups	  (see	  Paper	  I	  for	  a	  detailed	  description).	  
uAge	  was	  estimated	  as	  in	  Paper	  I,	  however	  age	  was	  solely	  used	  for	  a	  direct	  age	  adjusting	  of	  consumption	  at	  municipality	  and	  county	  level.	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Paper	  I	  Multivariate	  methods	  and	  ordination	  
Prescriptions	  were	  excluded	  from	  the	  raw	  data	  if	  they	  were	  connected	  to	  
institutions,	  included	  methenamine	  (ATC	  class	  J01XX05),	  if	  age,	  or	  gender,	  for	  
patient	  and	  prescriber	  were	  missing	  or	  non-­‐sense.	  Multiple	  entries	  on	  date,	  
patient	  ID	  and	  drug	  type	  were	  summarized	  and	  duplicates	  removed,	  negative	  
DDDs	  were	  excluded	  prior	  to	  aggregation.	  
Before	  running	  the	  multivariate	  analysis,	  we	  assembled	  ATC	  codes	  into	  8	  
antibiotic	  groups.	  These	  8	  groups	  were	  used	  as	  response	  variables	  and	  were	  
grouped	  accordingly:	  Tetracyclines,	  omitting	  doxycycline	  (J01AA),	  doxycycline	  
(J01AA02),	  phenoxymethylpenicillin	  (J01CE),	  extended	  spectrum	  penicillins	  
(J01CA),	  Trimethoprim	  (J01E),	  macrolides	  (J01FA),	  quinolones	  (J01M).	  
Remaining	  groups	  were	  organized	  in	  a	  non-­‐standardized	  group	  called	  “Others”.	  
For	  each	  year	  (7	  years)	  data	  were	  aggregated	  on	  the	  variables	  Patient	  age	  (8	  
groups),	  patient	  gender	  (2	  groups)	  prescriber	  age	  (4	  groups)	  and	  prescriber	  
gender	  (2	  groups)	  resulting	  in	  a	  table	  consisting	  of	  896	  rows	  each	  with	  8	  
response	  variables.	  Due	  to	  differences	  in	  dosages	  to	  children	  and	  adults	  the	  data	  
table	  was	  split	  into	  analyses	  for	  patients	  over	  and	  under	  12	  years	  of	  age.	  For	  
children	  we	  addressed	  only	  4	  groups	  of	  antibiotics,	  phenoxymethylpenicillin,	  
extended	  spectrum	  penicillins,	  macrolides	  and	  trimethoprim.	  
Correspondence	  Analysis	  (CA)	  is	  a	  multivariate	  ordination	  method	  that	  allows	  
inspection	  of	  data	  with	  multiple	  outcomes.	  It	  has	  previously	  been	  demonstrated	  
as	  a	  powerful	  tool	  for	  displaying	  data	  from	  contingency	  tables	  and	  its	  use	  in	  
medical	  research	  is	  documented	  elsewhere.138	  Foremost,	  CA	  allows	  visualisation	  
of	  complex	  tables,	  but	  is	  not	  intended	  for	  statistical	  inference	  such	  as	  classical	  
hypotheses	  testing.	  The	  two	  tables	  aggregated	  from	  NorPD	  data	  were	  processed	  
in	  a	  CA,	  and	  the	  results	  presented	  as	  biplots	  of	  the	  two	  principal	  axes.	  
We	  added	  a	  permutation	  procedure	  to	  assess	  the	  effect	  of	  the	  demographic	  
variables.	  We	  stratified	  data	  on	  year	  and	  used	  10	  000	  permutations	  of	  the	  data	  
for	  these	  tests.	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Paper	  II	  Regional	  difference	  in	  outpatient	  antibiotic	  consumption	  
Preparation	  of	  data	  was	  structured	  as	  for	  Paper	  I,	  except	  that	  we	  also	  removed	  
prescriptions	  with	  missing	  information	  on	  patient	  residence.	  Erroneous	  
municipality	  codes	  were	  manually	  corrected	  with	  information	  from	  Statistics	  
Norway	  on	  municipality	  codes.	  Patient	  age	  was	  used	  to	  perform	  a	  direct	  age	  
adjusting	  on	  both	  municipality	  and	  county	  level	  to	  avoid	  possible	  bias	  due	  to	  
different	  age	  structure	  in	  the	  administrative	  levels.	  DID	  for	  all	  antibiotics	  was	  
used	  as	  the	  response	  variable.	  	  
Selection	  of	  variables	  for	  the	  statistical	  model	  were	  supported	  by	  DAG	  
methodology	  through	  the	  browser-­‐based	  program,	  DAGitty	  version	  2.0.134,	  139	  We	  
considered	  variables	  available	  through	  NorPD,	  Statistics	  Norway,	  open	  source	  
data	  on	  geographical	  entities	  and	  unmeasured	  variables.	  We	  constructed	  a	  causal	  
diagram	  and	  chose	  the	  main	  effects	  from	  the	  minimal	  statistical	  model	  for	  
further	  analysis.	  After	  selection	  of	  variables	  we	  investigated	  their	  relationship:	  
DID	  at	  municipality	  level	  along	  a	  south-­‐north	  axis;	  DID	  as	  a	  function	  of	  number	  of	  
inhabitants	  in	  a	  municipality	  and	  finally	  the	  south-­‐north	  axis	  and	  the	  number	  of	  
inhabitants.	  Data	  structure	  revealed	  conditions	  that	  called	  for	  an	  alternative	  to	  
Ordinary	  Least	  Squares	  regression	  (OLS),	  and	  we	  estimated	  parameters	  for	  our	  
statistical	  model	  by	  using	  Quantile	  Regression	  (QR).140,	  141	  We	  assessed	  two	  
different	  models	  structures	  with	  AIC.	  One	  model	  where	  all	  variables	  interacted	  
was	  compared	  to	  a	  reduced	  model	  with	  the	  main	  effects.	  However,	  we	  let	  year	  of	  
dispensing	  interact	  with	  all	  variables	  in	  both	  models	  to	  avoid	  bias	  due	  to	  
temporal	  dependencies.	  
Finally,	  after	  selecting	  the	  model	  with	  the	  lowest	  AIC	  value	  we	  aggregated	  the	  
geographical	  variable	  in	  three	  different	  levels	  to	  assess	  if	  this	  affected	  parameter	  
results.	  This	  was	  used	  as	  a	  measure	  of	  MAUP142	  and	  the	  south-­‐north	  gradient	  
was	  considered	  at	  county	  level,	  municipality	  level	  and	  a	  south-­‐north	  ranking	  
solely	  based	  on	  latitude.	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Paper	  III	  Maintenance	  of	  genetic	  elements	  imposing	  a	  fitness	  cost	  
Relying	  on	  the	  experimental	  estimation	  of	  the	  fitness	  cost	  of	  newly	  acquired	  
class-­‐1	  integron	  we	  developed	  a	  mathematical	  model	  adapted	  from	  earlier	  
publications.114,	  143	  We	  used	  our	  experimental	  estimates	  and	  additional	  
parameters	  obtained	  from	  the	  literature	  to	  parameterize	  the	  model	  and	  
investigate	  under	  which	  environmental	  conditions	  genetic	  elements	  posing	  a	  
fitness	  cost	  could	  be	  maintained.	  
We	  simulated	  antibiotic	  pulses	  at	  different	  time	  points	  and	  evaluated	  how	  the	  
dynamics	  of	  5	  different	  bacterial	  populations	  interacted.	  We	  included	  a	  
population	  free	  of	  class-­‐1	  integrons	  that	  had	  a	  relative	  fitness	  of	  1.	  We	  further	  
included	  a	  population	  with	  a	  class-­‐1	  integron	  with	  one	  gene	  cassette	  encoding	  
antibiotic	  resistance	  and	  a	  relative	  fitness	  of	  0.93	  (range	  investigated:	  0.91	  -­‐	  
0.95).	  We	  allowed	  for	  a	  population	  with	  a	  class-­‐1	  integron	  with	  two	  gene	  
cassettes	  encoding	  antibiotic	  resistance	  towards	  two	  different	  antibiotics	  (same	  
fitness	  cost	  of	  integrase).	  Finally	  we	  included	  two	  populations	  with	  one	  and	  two	  
gene	  cassettes	  for	  antibiotic	  resistance,	  however	  allowing	  class-­‐1	  integrase	  to	  
mutate	  rendering	  it	  free	  of	  function	  and	  fitness	  cost.	  
Methodologically	  the	  mathematical	  model	  of	  Paper	  III	  is	  comparable	  to	  the	  
graphical	  presentation	  of	  DAG	  in	  Paper	  II.	  Other	  authors	  have	  addressed	  how	  
causal	  diagrams	  are	  related	  to	  compartmental	  models.	  These	  authors	  argue	  for	  
diagrams	  as	  an	  important	  tool	  to	  understand	  the	  system	  being	  studied,	  and	  pave	  
the	  way	  for	  statistical	  analysis	  of	  complex	  systems.144	  Further,	  compartmental	  
models	  are	  based	  on	  diagrams	  and	  in	  well	  known	  models	  such	  as	  the	  
Susceptible,	  Infected,	  Recovered	  epidemiological	  model	  (SIR).	  In	  this	  model	  
differential	  equations	  reflect	  the	  flow	  between	  the	  compartments.144,	  145	  Our	  
model	  in	  Paper	  III	  builds	  on	  the	  same	  framework	  as	  a	  general	  SIR	  model,	  with	  
alterations	  of	  the	  equations	  to	  fit	  the	  causal	  assumption	  of	  the	  system	  under	  
study.	  To	  derive	  such	  a	  system,	  we	  created	  a	  flow	  diagram	  to	  clarify	  and	  
illustrate	  the	  assumptions	  made,	  see	  Paper	  III	  supportive	  information.	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Summary	  of	  papers	  and	  main	  results	  
Paper	  I	  
Haugen	  P,	  Primicerio	  R,	  Simonsen	  GS,	  Furberg	  AS,	  Småbrekke	  L.	  Antibiotic	  
consumption	  profiles	  identified	  from	  a	  prescription	  database	  using	  multivariate	  
analysis	  [manuscript]	  
The	  study	  aimed	  at	  describing	  the	  Norwegian	  antibiotic	  consumption	  within	  age	  
and	  gender	  groups	  of	  patients	  and	  prescribers.	  Following	  the	  CA	  we	  identified	  
several	  patterns	  connected	  to	  prescriber	  and	  patient	  variables.	  
Prescriber	  age	  influences	  choice	  of	  antibiotics.	  Younger	  prescribers	  have	  a	  
higher	  proportion	  of	  prescriptions	  for	  phenoxymethylpenicillin.	  Older	  
prescribers	  favoured	  more	  broad-­‐spectrum	  alternatives,	  depending	  on	  patient	  
characteristics.	  	  
We	  also	  found	  prescriber	  gender	  differences	  within	  age	  strata	  of	  male	  patients.	  
Male	  prescribers	  had	  a	  higher	  proportion	  of	  trimethoprim,	  quinolones	  and	  
“other”	  antibiotics.	  Female	  prescribers	  had	  a	  higher	  proportion	  of	  doxycycline	  
and	  extended	  spectrum	  penicillins	  in	  their	  prescriptions	  to	  male	  patients	  above	  
60	  years.	  This	  pattern	  of	  differences	  between	  prescriber	  genders	  is	  not	  present	  
for	  the	  female	  patients,	  but	  can	  be	  observed	  for	  younger	  male	  patients.	  
Patient	  age	  and	  gender	  influences	  the	  antibiotic	  profiles	  we	  identified.	  There	  is	  a	  
high	  proportion	  of	  tetracyclines	  prescribed	  to	  young	  adult	  patients	  and	  a	  higher	  
proportion	  of	  doxycycline	  to	  the	  oldest	  patients.	  In	  general	  female	  patients	  have	  
profiles	  more	  closely	  related	  to	  broad-­‐spectrum	  alternatives.	  These	  are	  extended	  
spectrum	  penicillins,	  trimethoprim,	  doxycycline	  and	  other	  antibiotics.	  There	  is	  
an	  interaction	  between	  prescriber	  age	  and	  patient	  age.	  Older	  prescribers	  have	  a	  
higher	  proportion	  of	  broad-­‐spectrum	  alternatives	  within	  each	  patient	  age	  
stratum.	  
The	  results	  from	  Paper	  I	  demonstrate	  demographic	  differences	  in	  antibiotic	  
profiles.	  In	  the	  Norwegian	  population	  gender	  and	  age	  groups	  experience	  
different	  antibiotic	  profiles.	  Difference	  in	  amount	  and	  type	  of	  antibiotics	  between	  
age	  groups	  and	  genders	  have	  been	  described	  by	  other	  authors,	  both	  in	  Norway	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and	  in	  other	  countries.20,	  41,	  43,	  79,	  146,	  147	  Our	  results	  highlights	  that	  there	  is	  an	  
interaction	  between	  patient	  and	  prescriber	  demographic	  variables.	  Prescribers	  
have	  different	  antibiotic	  profiles	  within	  age	  strata	  of	  patients.	  Further,	  female	  
and	  male	  prescribers	  have	  different	  profiles	  when	  prescribing	  antibiotics	  to	  
males,	  but	  not	  to	  women.	  In	  Norway	  this	  phenomenon	  has	  not	  been	  described	  
previously.	  
Our	  findings	  imply	  that	  there	  are	  both	  patient,	  and	  prescriber	  clusters	  of	  
antibiotic	  profiles	  in	  the	  population.	  Therefore	  the	  selection	  pressure	  on	  bacteria	  
is	  different	  between	  and	  within	  demographic	  groups	  of	  patients.	  	  
We	  answered	  the	  aim	  of	  the	  project	  by	  identifying	  not	  only	  individual	  patient	  
and	  prescriber	  variables	  in	  prescription	  patterns,	  but	  also	  demonstrated	  
interaction	  between	  these	  variables.	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Paper	  II	  
Haugen	  P,	  Simonsen	  GS,	  Primicerio	  R,	  Furberg	  AS,	  Småbrekke	  L.	  Outpatient	  
antibiotic	  use	  in	  Norway	  depends	  on	  municipality	  population	  size	  [manuscript]	  
The	  aim	  of	  the	  paper	  was	  to	  investigate	  regional	  differences	  in	  antibiotic	  
consumption	  in	  Norway.	  
There	  is	  a	  6-­‐10	  fold	  variation	  in	  antibiotic	  consumption,	  measured	  in	  dispensed	  
DID	  between	  Norwegian	  municipalities.	  Both	  at	  county	  and	  municipality	  level	  it	  
appears	  that	  the	  consumption	  declines	  with	  latitude.	  However,	  adjusting	  for	  
population	  size	  in	  municipalities	  demonstrates	  that	  the	  consumption	  depends	  on	  
population	  size,	  latitude	  and	  the	  interaction	  between	  these.	  The	  south-­‐north	  
decline	  in	  antibiotic	  consumption	  diminishes	  with	  increasing	  municipality	  
population	  size.	  The	  results	  are	  consistent	  between	  the	  20th	  and	  the	  80th	  
percentile.	  This	  indicates	  similar	  effects	  of	  the	  variables	  among	  municipalities	  
with	  high	  and	  low	  antibiotic	  consumption.	  	  
Different	  levels	  of	  aggregating	  municipalities,	  which	  give	  some	  reassurance	  
towards	  MAUP	  effects,	  do	  not	  affect	  the	  main	  results.	  	  We	  cannot	  however,	  fully	  
exclude	  these	  effects.	  We	  found	  no	  support	  for	  yearly	  differences	  when	  we	  
estimated	  the	  effects	  between	  year	  and	  any	  of	  the	  included	  variables.	  
Recently	  Norwegian	  regional	  differences	  have	  been	  addressed	  in	  reports	  where	  
the	  difference	  in	  total	  DID	  and	  prevalence	  of	  prescribing	  has	  been	  reported	  to	  
differ	  between	  counties	  and	  health	  regions.17,	  148	  We	  demonstrate	  that	  this	  effect	  
is	  to	  a	  large	  extent	  related	  to	  municipality	  population	  size.	  	  By	  aggregating	  
consumption	  data	  over	  several	  municipalities,	  variation	  within	  counties	  and	  
health	  regions	  are	  lost.	  It	  is	  important	  to	  acknowledge	  that	  there	  is	  substantial	  
variation	  between	  municipalities	  within	  a	  county	  (and	  health	  region),	  and	  this	  
variation	  has	  to	  be	  considered	  in	  analysis	  of	  data.	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Paper	  III	  
Starikova	  I,	  Harms	  K,	  Haugen	  P,	  Lunde	  TTM,	  Primicerio	  R,	  Samuelsen	  Ø,	  Nielsen	  
KM,	  Johnsen	  PJ.	  A	  trade-­‐off	  between	  the	  fitness	  cost	  of	  functional	  integrases	  and	  
long-­‐term	  stability	  of	  integrons,	  PLOS	  pathogens	  2012;	  8(11)	  
We	  aimed	  at	  determining	  the	  fitness	  cost	  of	  newly	  acquired	  integrons	  and	  model	  
conditions	  that	  favoured	  maintenance	  of	  both	  functional	  and	  non-­‐functional	  
integrases	  in	  bacterial	  populations.	  
Initially,	  a	  newly	  acquired	  integron	  in	  Acitenobacter	  baylyi	  led	  to	  a	  fitness	  cost.	  
However,	  when	  mutating	  the	  integrases	  experimentally,	  the	  cost	  related	  to	  the	  
integron	  was	  reduced.	  This	  also	  happened	  during	  experimental	  evolution	  were	  
bacteria	  were	  able	  to	  mitigate	  the	  cost	  of	  the	  acquired	  integrons	  after	  30	  –	  42	  
days.	  
The	  mathematical	  model	  predicted	  loss	  of	  the	  functional	  integrases	  in	  the	  
bacterial	  population	  when	  selection	  pressure	  imposed	  by	  antibiotic	  drugs	  was	  
absent.	  	  
The	  combination	  of	  a	  theoretical	  model	  and	  laboratory	  experiments	  showed	  that	  
antibiotic	  pulses	  as	  far	  apart	  as	  40	  days	  would	  favour	  maintenance	  of	  integrases	  
in	  bacterial	  populations,	  under	  laboratory	  conditions.	  
Using	  a	  combination	  of	  both	  laboratory	  and	  theoretical	  approaches	  we	  conclude	  
that	  initially	  costly	  integrons	  can	  be	  maintained	  in	  bacterial	  populations.	  We	  
demonstrate	  that	  time	  between	  selective	  events	  (i.e.	  antibiotic	  selection)	  is	  the	  
key	  parameter	  under	  the	  conditions	  explored.	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Discussion	  
The	  recent	  report	  by	  the	  WHO	  on	  surveillance	  of	  antimicrobial	  resistance	  
highlights	  several	  microbes	  as	  especially	  worrying	  in	  an	  international	  public	  
health	  perspective.89	  Among	  these	  we	  find	  the	  species	  Escherichia	  coli,	  Klebsiella	  
pneumoniae,	  Staphylococcus	  aureus	  and	  Streptococcus	  pneumonia.	  These	  bacteria	  
may	  potentially	  cause	  lethal	  infections,	  and	  their	  resistance	  against	  several	  
antibiotics	  is	  threatening	  effective	  treatments	  worldwide.	  The	  Centres	  for	  
Disease	  Control	  and	  prevention	  (CDC)	  list	  seven	  bacteria,	  or	  groups	  of	  bacteria,	  
carrying	  antibiotic	  resistance	  genes	  that	  cause	  particular	  concern.	  Among	  these	  
we	  find	  the	  Carbapenem-­‐Resistant	  Enterobacteriaceae	  (CRE)	  and	  multidrug	  
resistant	  Salmonella	  spp.	  The	  CDC	  estimates	  that	  CRE	  are	  responsible	  for	  600	  
deaths	  in	  the	  USA	  annually	  and	  that	  the	  cost	  related	  to	  drug	  resistant	  non-­‐
typhoidal	  Salmonella	  spp.	  infections	  are	  in	  the	  range	  of	  	  $	  365	  million	  
annually.149	  Recently	  investigators	  found	  evidence	  for	  an	  increase	  in	  the	  use	  of	  
antibiotics	  for	  acute	  bronchitis	  in	  the	  US	  between	  1996	  and	  2010.	  This	  was	  in	  
contrast	  to	  advices	  given	  by	  CDC	  to	  American	  practitioners.150	  
Investigators	  have	  tried	  to	  address	  the	  cost	  of	  antibiotic	  resistance	  on	  healthcare	  
systems.	  However	  antibiotics	  have	  become	  such	  an	  integrated	  part	  of	  healthcare	  
that	  estimating	  the	  cost	  is	  an	  overwhelming	  task.	  It	  is	  not	  only	  treatment	  of	  
infectious	  diseases	  that	  will	  be	  affected,	  because	  the	  entire	  healthcare	  system	  
relies	  on	  the	  effect	  of	  antibiotics.151	  
This	  illustrates	  the	  importance	  of	  reducing	  antibiotic	  consumption.	  Reduced	  
levels	  of	  consumption	  will	  lower	  selection	  for	  resistance	  determinants	  in	  
bacterial	  populations.	  Reducing	  and	  preventing	  antibiotic	  resistance	  is	  one	  of	  the	  
major	  health	  related	  challenges	  for	  both	  international	  and	  Norwegian	  health	  
authorities.89,	  148	  	  
A	  recent	  comment	  in	  Lancet	  Infectious	  Diseases	  calls	  for	  studies	  of	  regional	  
antibiotic	  consumption	  within	  countries,	  and	  the	  authors	  also	  stress	  the	  need	  for	  
studies	  investigating	  determinants	  for	  antibiotics	  consumption.152	  In	  Europe,	  
information	  on	  consumption	  and	  resistance	  is	  extensive,	  and	  a	  number	  of	  studies	  
on	  antibiotic	  consumption	  are	  available.15,	  37,	  50,	  56,	  59,	  60,	  153	  This	  is	  in	  contrasts	  to	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other	  regions	  of	  the	  world	  were	  certified	  laboratories	  for	  microbiological	  
diagnostics	  and	  surveillance	  systems	  are	  scarce.89	  The	  Nordic	  countries,	  with	  a	  
general	  low	  consumption,	  have	  well	  integrated	  routines	  for	  reporting	  
consumption	  and	  resistance.11,	  29,	  154,	  155	  In	  Papers	  I	  and	  II	  we	  present	  a	  
comprehensive	  overview	  of	  Norwegian	  antibiotic	  consumption	  related	  to	  
demographic	  variables	  and	  geography.	  The	  methodology	  used	  in	  these	  
manuscripts	  helped	  to	  detect	  several	  patterns	  of	  consumption	  that	  have	  not	  
previously	  been	  described	  in	  Norway.	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Methodological	  considerations	  
Whether	  pharmacoepidemiological	  studies	  rely	  on	  ecological	  or	  individual	  data	  
they	  share	  a	  common	  goal:	  address	  patterns	  of	  consumption	  in	  a	  population	  to	  
aid	  in	  decision	  making	  for	  treatment	  of	  disease.156	  New	  methods	  are	  constantly	  
being	  developed,	  or	  implemented,	  in	  healthcare	  research	  to	  address	  studies	  with	  
complex	  data	  structure.139,	  157	  	  Two	  challenges	  confront	  researchers	  working	  
with	  the	  large	  and	  complex	  datasets	  characteristic	  of	  pharmacoepidemiological	  
studies.	  Firstly	  how	  to	  investigate	  complex	  causal	  relationships,	  and	  secondly	  
how	  to	  cope	  with	  multiple,	  correlated	  response	  variables.	  
Multivariable	  regressions	  are	  predominant	  in	  pharmacoepidemiological	  
investigations	  of	  antibiotic	  consumption.32,	  33,	  47,	  48,	  74,	  82,	  85	  	  The	  use	  of	  p	  values	  as	  
inferential	  tools	  to	  choose	  statistical	  models	  are	  commonly	  encountered.	  From	  
my	  perspective,	  the	  choice	  of	  a	  statistical	  model	  to	  explain	  the	  underlying	  data	  
structure	  is	  of	  paramount	  importance	  in	  statistical	  inference,	  but	  overlooked	  in	  
several	  published	  studies.	  The	  choice	  of	  significance	  testing	  in	  a	  multiple	  
regression	  setting	  is	  predominant,	  but	  not	  without	  controversy.144,	  158	  Some	  
authors	  have	  argued	  for	  the	  implementation	  of	  information	  criteria	  instead	  of	  
traditional	  hypothesis	  testing.159,	  160	  Among	  the	  available	  information	  criteria	  for	  
model	  selection	  the	  AIC	  is	  recommended,	  although	  alternatives	  exists	  depending	  
on	  type	  of	  analysis	  and	  data	  structure.159	  In	  fact,	  there	  are	  strong	  arguments	  
against	  using	  classical	  hypothesis	  testing	  as	  a	  method	  of	  statistical	  inference	  in	  
multiple	  regressions.	  However,	  the	  alternative	  use	  of	  information	  criteria	  for	  
model	  selection	  also	  comes	  with	  a	  risk	  of	  selecting	  sub	  optimal	  models,	  
especially	  if	  there	  is	  a	  high	  degree	  of	  uncertainty	  associated	  with	  measurement	  
errors.144,	  159	  Discussions	  on	  the	  topic	  have	  moved	  from	  the	  scientific,	  and	  
philosophical,	  literature	  over	  to	  blogs	  and	  a	  well-­‐structured	  post	  on	  the	  topic	  has	  
been	  published	  online.161	  	  
Traditionally,	  goodness	  of	  fit	  estimates	  for	  selection	  of	  linear	  regression	  models	  
have	  relied	  on	  R2	  values.	  R2	  measures	  the	  amount	  of	  variance	  accounted	  by	  the	  
regression	  model.	  However,	  in	  a	  multivariable	  setting	  R2	  is	  not	  favourable	  as	  a	  
selection	  criterion	  for	  models.	  The	  amount	  of	  variance	  explained	  increases	  as	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more	  terms	  are	  added	  to	  the	  statistical	  model,	  thus	  selecting	  for	  larger	  models	  
and	  ignoring	  the	  principle	  of	  parsimony.162	  
In	  addition	  to	  the	  use	  of	  information	  criteria	  in	  model	  selection	  causal	  diagrams	  
and	  DAG	  have	  been	  implemented	  into	  medical	  research	  when	  specifying	  
candidate	  models.139,	  163	  Easily	  accessible	  online	  tools	  with	  well-­‐defined	  user	  
guides	  exist,	  alongside	  more	  code	  demanding	  technical	  solutions,	  for	  the	  
implementation	  of	  causal	  analysis	  to	  avoid	  bias.134,	  164	  Despite	  the	  availability	  of	  
DAG	  tools	  this	  methodology	  has	  not	  been	  considered	  in	  
pharmacoepidemiological	  studies	  concerning	  antibiotic	  consumption.	  Although	  
methodological	  examples	  exist,	  an	  extensive	  search	  of	  the	  literature	  for	  
combinations	  of	  “antimicrobial”,	  “epidemiology”	  and	  “causal	  diagrams”	  revealed	  
no	  pharmacoepidemiological	  studies	  focusing	  on	  antibiotics	  and	  DAG	  
methodology.	  However,	  recent	  studies	  have	  implemented	  interesting	  new	  
methodology	  on	  variable	  selection	  within	  the	  General	  Estimating	  Equations	  
(GEE)	  setting.	  These	  authors	  used	  a	  penalized	  GEE	  as	  a	  data-­‐mining	  tool	  to	  build	  
statistical	  models	  in	  longitudinal	  data.165,	  166	  
Multivariate	  analyses	  rely	  on	  statistical	  tools	  for	  investigating	  data	  with	  multiple	  
outcome	  variables.138,	  167	  The	  expression	  multivariate	  analysis	  is	  sometimes	  
misinterpreted	  in	  pharmacoepidemiological	  literature	  in	  studies	  that	  are	  in	  fact	  
multivariable.76,	  79,	  80	  	  A	  multitude	  of	  multivariate,	  ordination	  techniques	  exists	  
that	  allow	  to	  summarize	  relationship	  among	  dependent	  variables.	  Among	  these	  
we	  find	  Principal	  Components	  Analysis	  (PCA),	  and	  CA.168	  	  
The	  databases	  found	  in	  the	  Nordic	  countries	  allow	  connection	  of	  these	  data	  to	  
other	  sources	  of	  information.	  Data	  dredging	  a	  serious	  concern	  in	  studies	  
attempting	  to	  address	  hypothesis	  testing,	  especially	  when	  the	  vast	  amount	  of	  
data	  is	  taken	  into	  consideration.159	  Multivariate	  analysis	  avoids	  this	  challenge,	  by	  
focusing	  on	  pattern	  discovery	  and	  characterization	  rather	  than	  hypothesis	  
testing.	  Large	  contingency	  tables	  can	  be	  expressed	  in	  a	  two-­‐dimensional	  space	  
with	  the	  aid	  of	  a	  CA	  and	  a	  biplot,	  and	  several	  types	  of	  studies	  can	  benefit	  from	  
these	  graphical	  techniques	  to	  summarize	  multidimensional	  results	  in	  one	  
figure.138	  Evaluation	  and	  implementation	  of	  tools	  for	  data	  mining	  has	  been	  called	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for	  in	  the	  field	  of	  pharmacoepidemiology,	  both	  CA	  and	  PCA	  are	  techniques	  that	  
can	  meet	  some	  of	  these	  demands.169	  
Recently,	  in	  a	  paper	  including	  Italian	  prescriptions,	  the	  authors	  used	  network	  
analysis	  as	  a	  data-­‐mining	  tool	  on	  prescription	  data	  to	  investigate	  which	  classes	  of	  
drugs	  that	  are	  co-­‐prescribed.170	  This	  investigation	  shows	  how	  patients	  below	  30	  
years	  of	  age	  have	  more	  connections	  between	  antibiotics	  and	  respiratory	  and	  
hormonal	  drugs	  than	  older	  age	  groups.	  	  
Whereas	  regression	  modelling	  is	  frequently	  used	  in	  pharmacoepidemiology,	  
mathematical	  models	  are	  less	  frequent.	  A	  review	  of	  the	  impact	  of	  mathematical	  
models	  in	  epidemiology	  has	  pointed	  out	  that	  articles	  containing	  mathematical	  
modelling	  is	  among	  the	  top	  cited	  articles,	  and	  that	  the	  number	  of	  such	  papers	  are	  
increasing.171	  In	  the	  antibiotic	  resistance	  perspective	  mathematical	  modelling	  is	  
frequent,	  and	  several	  papers	  address	  population	  biology	  of	  bacteria,	  but	  also	  
transmission	  dynamics	  both	  within	  and	  outside	  hospitals.5,	  114,	  123,	  143,	  171-­‐173	  
In	  Norway	  the	  systematic	  registration	  of	  antibiotic	  sales	  to	  patients	  has	  resulted	  
in	  a	  large,	  comprehensive	  database.	  Therefore,	  analysis	  of	  outpatient	  antibiotic	  
consumption	  provides	  the	  richest	  source	  of	  information	  to	  address	  the	  major	  
antibiotic	  use,	  and	  possibly	  the	  main	  cause	  of	  selection	  pressure	  on	  bacteria	  in	  
the	  country.	  The	  complex	  character	  of	  these	  data	  calls	  for	  an	  upgrade	  of	  the	  
statistical	  tools	  used	  in	  pharmacoepidemiological	  investigations	  of	  patterns	  and	  
causality.	  Combinations	  of	  mathematical	  modelling	  and	  data	  mining	  tools	  such	  as	  
network	  analysis	  and	  multivariate	  methods	  opens	  for	  interesting	  in-­‐depth	  
analyses	  of	  these	  routinely	  collected	  data.	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Limitation	  of	  studies	  
Paper	  I	  and	  II	  are	  based	  on	  data	  from	  a	  national	  prescription	  database	  with	  
mandatory	  entries,	  and	  the	  following	  limitations	  should	  be	  considered.	  
Although	  individual	  data	  are	  available	  in	  NorPD,	  we	  used	  aggregated	  to	  meet	  the	  
intended	  degree	  of	  resolution	  and	  for	  ease	  of	  interpretation.	  Further,	  the	  
aggregation	  reduced	  computing	  time,	  and	  reduced	  response	  variables	  into	  
interpretable	  categories.	  However,	  the	  aggregation	  reduced	  information	  and	  
decreased	  variation	  in	  the	  data.	  The	  patterns	  that	  occur	  in	  the	  CA	  are	  therefore	  
not	  from	  individual	  prescriptions,	  but	  from	  the	  groups	  that	  were	  chosen	  for	  
aggregation.	  	  
In	  paper	  II	  we	  modelled	  relationships	  between	  variables	  as	  linear	  dependencies.	  
The	  relationship	  between	  antibiotic	  consumption	  and	  municipality	  size	  indicates	  
that	  this	  is	  a	  coarse	  approximation.	  Given	  the	  non-­‐linear	  response	  the	  linear	  
model	  will	  capture	  the	  sign	  and	  magnitude	  of	  the	  relationship	  but	  it	  should	  not	  
be	  used	  for	  prediction.	  For	  prediction	  a	  model	  considering	  nonlinear	  terms	  
should	  be	  considered.	  The	  advantages	  of	  linear	  models	  are	  the	  ease	  of	  
interpretation,	  the	  robustness	  of	  estimates	  and	  perhaps	  the	  familiarity	  of	  linear	  
regression.	  In	  a	  paper	  to	  the	  Journal	  of	  the	  American	  statistical	  association	  
George	  E.	  P.	  Box	  comments	  on	  the	  question	  on	  normality	  and	  linearity:	  
“Equally	  the	  statistician	  knows,	  for	  example,	  that	  in	  true	  nature	  there	  never	  
was	  a	  straight	  line,	  yet	  with	  normal	  and	  linear	  assumptions,	  known	  to	  be	  
false,	  he	  can	  often	  derive	  results	  which	  match,	  to	  a	  useful	  approximation,	  
those	  found	  in	  the	  real	  world.”	  174	  
	  Compartmental	  models,	  DAGs	  and	  diagrams	  are	  excellent	  tools	  for	  structuring	  
data	  analysis.	  These	  methods	  allow	  researchers	  to	  get	  an	  overview	  of	  a	  study	  
through	  visualisation	  of	  the	  system.	  However,	  there	  is	  a	  risk	  of	  oversimplifying	  
very	  complex	  systems	  into	  a	  selection	  of	  “available	  variables”.	  Further,	  a	  
preliminary	  study	  of	  the	  expected	  causal	  diagram	  prior	  to	  analysis	  would	  be	  
beneficial	  to	  avoid	  the	  researcher	  adapting	  the	  causal	  model	  to	  the	  data	  
structure.144	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Implications	  of	  the	  studies	  
In	  Paper	  I	  we	  show	  how	  demographic	  variables	  shape	  clusters	  of	  different	  
antibiotic	  profiles	  in	  the	  Norwegian	  population.	  In	  Paper	  II	  we	  show	  how	  the	  
volume	  of	  antibiotics	  prescribed	  vary	  in	  space	  within	  Norway.	  Among	  
municipalities	  the	  variation	  in	  total	  outpatient	  antibiotic	  consumption	  is	  
substantial.	  This	  opens	  for	  a	  scenario	  where	  amount	  of	  consumed	  antibiotics	  
vary	  between	  demographic	  groups	  across	  municipalities.	  	  In	  an	  antibiotic	  
resistance	  perspective	  this	  is	  of	  great	  interest,	  as	  the	  selective	  pressure	  imposed	  
on	  bacteria	  will	  vary	  depending	  both	  on	  demographic	  groups	  and	  administrative	  
units.	  If	  selection	  pressure	  is	  high	  within	  a	  specific	  demographic	  group	  this	  effect	  
can	  be	  further	  enhanced	  through	  transmission	  dynamics.	  Analyses	  of	  social	  
networks	  have	  shown	  that	  contact	  and	  possible	  transmission	  of	  disease	  happens	  
within	  age-­‐strata	  of	  a	  population,	  especially	  when	  the	  prevalence	  of	  disease	  is	  
low.175	  Age	  is	  an	  important	  factor	  for	  creating	  clusters	  in	  social	  networks;	  
however,	  this	  depends	  on	  the	  interaction	  between	  nodes.176	  	  
Although	  differences	  in	  antibiotic	  consumption	  can	  be	  found	  between	  clusters	  of	  
the	  population,	  differences	  in	  antibiotic	  resistance	  among	  demographic	  groups	  
are	  not	  frequently	  reported.	  Some	  studies	  do	  however	  point	  to	  age	  and	  gender	  
related	  differences	  in	  proportion	  of	  antibiotic	  resistant	  bacteria.	  In	  the	  US,	  age	  of	  
patient	  has	  been	  shown	  to	  be	  a	  predictor	  for	  antibiotic	  resistance	  in	  patients	  
suffering	  from	  urinary	  tract	  infections.	  Patient	  over	  65	  years	  had	  a	  higher	  risk	  for	  
an	  infection	  with	  bacteria	  resistant	  towards	  at	  least	  two	  antibiotics.177	  In	  a	  UK	  
study,	  male	  patients	  with	  tuberculosis	  were	  more	  likely	  to	  have	  multidrug	  
resistant	  infections	  than	  women.178	  In	  Australia	  it	  has	  been	  shown	  that	  
indigenous	  people	  are	  at	  increased	  risk	  of	  having	  a	  methicillin	  resistant	  
Staphylococcus	  aureus	  infection.179	  In	  2012	  the	  EARS-­‐Net	  report	  investigated	  
demographic	  factors	  related	  to	  resistance	  in	  three	  species	  of	  bacteria.	  They	  
found	  that	  males	  had	  higher	  proportion	  of	  E.	  coli	  and	  K.	  pneumonia	  resistant	  
towards	  fluoroquinolones,	  3rd	  generation	  cephalosporins	  and	  aminoglycosides	  
than	  females.	  The	  proportion	  of	  resistant	  E.	  coli	  increased	  with	  age,	  whereas	  for	  
K.	  pneumonia	  the	  proportion	  decreased	  as	  patient	  age	  increased.	  Combined	  
resistance	  in	  P.	  aeruginosa	  was	  defined	  as	  bacteria	  resistant	  towards	  three	  or	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more	  antibiotic	  classes.	  For	  these	  bacteria	  the	  oldest	  patients	  had	  the	  lowest	  
resistance	  proportions.180	  	  
Study	  III	  illustrates	  how	  pulses	  of	  multiple	  antibiotics	  can	  favour	  multidrug	  
resistance	  in	  bacterial	  populations.	  Bacteria	  harbouring	  integrons	  can	  spread	  
within	  demographic	  groups	  with	  a	  specific	  antibiotic	  profile	  and	  thereby	  
experience	  the	  necessary	  heterogeneity	  required	  for	  a	  functional	  integrase.	  If	  
gene	  cassettes	  harbouring	  antibiotic	  resistance	  are	  integrated,	  selection	  of	  
antibiotic	  resistant	  bacteria	  within	  a	  demographic	  group	  will	  occur.	  Integrons	  
can	  harbour	  several	  gene	  cassettes.	  Selection	  of	  one	  antibiotic	  can	  indirectly	  
select	  for	  the	  other	  acquired	  gene	  cassettes,	  thus	  effectively	  maintaining	  
multidrug	  resistance.	  This	  shows	  how	  the	  combination	  of	  clusters	  with	  specific	  
antibiotic	  consumption	  and	  transmission	  opens	  for	  selective	  windows	  that	  could	  
contribute	  to	  the	  evolution	  of	  antibiotic	  multidrug	  resistance.	  	  
A	  combination	  of	  analysis	  of	  resistance	  patterns	  and	  theoretical	  modelling	  can	  
answer	  if	  our	  laboratory	  and	  theoretical	  results	  can	  have	  an	  impact	  on	  evolution	  
of	  resistant	  bacteria	  in	  Norwegian	  outpatients.	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Conclusions	  
In	  Paper	  I	  we	  identified	  patterns	  among	  patient	  and	  prescriber	  variables	  that	  
form	  clusters	  of	  antibiotic	  consumption	  and	  prescribing.	  We	  showed	  how	  
prescriber	  age	  influence	  antibiotic	  prescription	  profiles	  and	  that	  there	  is	  an	  
interaction	  between	  demographic	  variables	  for	  both	  patient	  and	  prescriber.	  
In	  Paper	  II	  we	  found	  a	  maximum	  of	  a	  10-­‐fold	  difference	  in	  the	  outpatient	  
antibiotic	  consumption	  when	  investigating	  Norwegian	  municipalities.	  
Consumption	  in	  municipalities	  with	  small	  population	  sizes	  have	  decreasing	  
consumption	  along	  a	  south-­‐north	  axis,	  this	  effect	  is	  not	  present	  for	  municipalities	  
when	  population	  size	  increases.	  
In	  Paper	  III	  We	  found	  that	  the	  fitness	  cost	  of	  integrons	  are	  mitigated	  through	  
bacterial	  evolution,	  and	  that	  heterogenic	  environments	  in	  the	  form	  of	  antibiotic	  
pulses	  aids	  in	  maintaining	  a	  functional	  integrase.	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Future	  aspect	  
A	  natural	  continuation	  of	  Paper	  I	  would	  be	  to	  investigate	  the	  difference	  in	  
prescription	  profiles	  between	  age	  groups	  of	  prescribers	  including	  indication	  of	  
disease.	  Are	  the	  differences	  due	  to	  prescriber	  habits,	  or	  can	  they	  be	  explained	  
through	  differences	  in	  diseases	  treated	  within	  the	  age	  strata	  of	  prescribers?	  
The	  observed	  gender	  difference	  between	  female	  and	  male	  prescribers	  regarding	  
prescriptions	  to	  male	  patients	  should	  be	  further	  investigated	  to	  identify	  possible	  
predictors	  of	  this	  difference.	  
The	  results	  from	  Paper	  I	  can	  also	  be	  used	  to	  target	  patient	  age,	  or	  gender,	  groups	  
with	  the	  aim	  of	  reducing	  consumption	  of	  specific	  antibiotic	  types.	  
CA	  could	  also	  be	  implemented	  into	  reporting	  on	  antibiotic	  consumption	  in	  both	  
national	  and	  international	  reports.	  ESAC	  and	  NORM/NORM-­‐VET	  reports	  are	  
areas	  where	  such	  graphic	  displays	  can	  aid	  in	  understanding	  complex	  tables	  of	  
consumption.	  
An	  interesting	  development	  of	  Papers	  I	  to	  III	  would	  be	  to	  combine	  the	  
information	  obtained	  into	  computer	  simulations.	  Demographic	  differences	  in	  
consumption	  profiles,	  regional	  differences	  in	  antibiotic	  consumption	  and	  the	  
effect	  of	  periodic	  selection	  on	  bacteria	  can	  be	  combined	  with	  existing	  knowledge	  
on	  network	  transmissions.	  This	  could	  aid	  in	  increasing	  the	  understanding	  of	  how	  
resistant	  bacteria	  evolve	  and	  spread	  in	  the	  outpatient	  setting.	  
	  
	   	  
	   51	  
References	  
1.	   World	  Health	  Organization.	  Tackling	  antibiotic	  resistance	  from	  a	  food	  
safety	  perspective	  in	  Europe:	  World	  health	  organization	  regional	  office	  for	  
Europe;	  2011.	  
2.	   WHO	  Collaborating	  centre	  for	  drug	  statistics	  methodology.	  Definition	  and	  
general	  considerations,	  
http://www.whocc.no/ddd/definition_and_general_considera/.	  
Norwegian	  institute	  of	  puplic	  health,.	  Accessed	  18.08,	  2014.	  
3.	   Bergstrom	  CT,	  Feldgarden	  M.	  The	  ecology	  and	  evolution	  of	  antibiotic-­‐
resistant	  bacteria.	  Evolution	  in	  health	  and	  disease.	  2008.	  
4.	   Antonovics	  J,	  Abbate	  JL,	  Baker	  CH,	  et	  al.	  Evolution	  by	  any	  other	  name:	  
Antibiotic	  resistance	  and	  avoidance	  of	  the	  E-­‐word.	  Plos	  Biology.	  
2007;5(2):	  137-­‐140.	  
5.	   Austin	  DJ,	  Kristinsson	  KG,	  Anderson	  RM.	  The	  relationship	  between	  the	  
volume	  of	  antimicrobial	  consumption	  in	  human	  communities	  and	  the	  
frequency	  of	  resistance.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  
the	  United	  States	  of	  America.	  1999;96(3):	  1152-­‐1156.	  
6.	   Allen	  HK,	  Donato	  J,	  Wang	  HH,	  et	  al.	  Call	  of	  the	  wild:	  antibiotic	  resistance	  
genes	  in	  natural	  environments.	  Nature	  reviews.	  Microbiology.	  2010;8(4):	  
251-­‐259.	  
7.	   D'Costa	  VM,	  King	  CE,	  Kalan	  L,	  et	  al.	  Antibiotic	  resistance	  is	  ancient.	  Nature.	  
2011;477(7365):	  457-­‐461.	  
8.	   Knapp	  CW,	  Dolfing	  J,	  Ehlert	  PA,	  et	  al.	  Evidence	  of	  increasing	  antibiotic	  
resistance	  gene	  abundances	  in	  archived	  soils	  since	  1940.	  Environmental	  
science	  &	  technology.	  2010;44(2):	  580-­‐587.	  
9.	   Bhullar	  K,	  Waglechner	  N,	  Pawlowski	  A,	  et	  al.	  Antibiotic	  resistance	  is	  
prevalent	  in	  an	  isolated	  cave	  microbiome.	  PLoS	  ONE.	  2012;7(4):	  e34953.	  
10.	   Rogues	  AM,	  Dumartin	  C,	  Amadeo	  B,	  et	  al.	  Relationship	  between	  rates	  of	  
antimicrobial	  consumption	  and	  the	  incidence	  of	  antimicrobial	  resistance	  
in	  Staphylococcus	  aureus	  and	  Pseudomonas	  aeruginosa	  isolates	  from	  47	  
French	  hospitals.	  Infection	  Control	  and	  Hospital	  Epidemiology.	  
2007;28(12):	  1389-­‐1395.	  
11.	   Meyer	  E,	  Gastmeier	  P,	  Deja	  M,	  et	  al.	  Antibiotic	  consumption	  and	  
resistance:	  data	  from	  Europe	  and	  Germany.	  Ijmm	  International	  Journal	  of	  
Medical	  Microbiology.	  2013;303(6-­‐7):	  388-­‐395.	  
12.	   Kristinsson	  KG.	  Effect	  of	  antimicrobial	  use	  and	  other	  risk	  factors	  on	  
antimicrobial	  resistance	  in	  pneumococci.	  Microbial	  Drug	  Resistance-­‐
Mechanisms	  Epidemiology	  and	  Disease.	  1997;3(2):	  117-­‐123.	  
13.	   Bergman	  M,	  Nyberg	  ST,	  Huovinen	  P,	  et	  al.	  Association	  between	  
antimicrobial	  consumption	  and	  resistance	  in	  Escherichia	  coli.	  
Antimicrobial	  Agents	  and	  Chemotherapy.	  2009;53(3):	  912-­‐917.	  
14.	   Bartoloni	  A,	  Bartalesi	  F,	  Mantella	  A,	  et	  al.	  High	  prevalence	  of	  acquired	  
antimicrobial	  resistance	  unrelated	  to	  heavy	  antimicrobial	  consumption.	  
Journal	  of	  Infectious	  Diseases.	  2004;189(7):	  1291-­‐1294.	  
15.	   Goossens	  H,	  Ferech	  M,	  Stichele	  RV,	  et	  al.	  Outpatient	  antibiotic	  use	  in	  
Europe	  and	  association	  with	  resistance:	  a	  cross-­‐national	  database	  study.	  
Lancet.	  2005;365(9459):	  579-­‐587.	  
	   52	  
16.	   Metz-­‐Gercek	  S,	  Maieron	  A,	  Strauss	  R,	  et	  al.	  Ten	  years	  of	  antibiotic	  
consumption	  in	  ambulatory	  care:	  trends	  in	  prescribing	  practice	  and	  
antibiotic	  resistance	  in	  Austria.	  Bmc	  Infectious	  Diseases.	  2009;9:	  61.	  
17.	   NORM/NORM-­‐VET.	  Usage	  of	  antimicrobial	  agents	  and	  occurrence	  of	  
antimicrobial	  resistance	  in	  Norway	  2012.	  Tromsø	  /	  Oslo	  2013.	  
18.	   SWEDRES-­‐SVARM	  2012.	  Use	  of	  antimicrobials	  and	  occurence	  of	  
antimicrobial	  resistance	  in	  Sweden.	  Solna/Uppsala	  2013.	  
19.	   DANMAP	  2012.	  Use	  of	  antimicrobial	  agents	  and	  occurrence	  of	  
antimicrobial	  resistance	  in	  bacteria	  from	  food	  animals,	  food	  and	  humans	  in	  
Denmark.	  Copenhagen	  2013.	  
20.	   Blix	  HS,	  Engeland	  A,	  Litleskare	  I,	  et	  al.	  Age-­‐	  and	  gender-­‐specific	  
antibacterial	  prescribing	  in	  Norway.	  Journal	  of	  Antimicrobial	  
Chemotherapy.	  2007;59(5):	  971-­‐976.	  
21.	   Dréno	  B,	  Thiboutot	  D,	  Gollnick	  H,	  et	  al.	  Large-­‐scale	  worldwide	  
observational	  study	  of	  adherence	  with	  acne	  therapy.	  International	  Journal	  
of	  Dermatology.	  2010;49(4):	  448-­‐456.	  
22.	   Axelsson	  M.	  Report	  on	  personality	  and	  adherence	  to	  antibiotic	  therapy:	  a	  
population-­‐based	  study.	  BMC	  Psychology.	  2013;1(1):	  24.	  
23.	   Kardas	  P.	  Patient	  compliance	  with	  antibiotic	  treatment	  for	  respiratory	  
tract	  infections.	  Journal	  of	  Antimicrobial	  Chemotherapy.	  2002;49(6):	  897-­‐
903.	  
24.	   European	  centre	  for	  disease	  prevention	  and	  control.	  Surveillance	  of	  
antimicrobial	  consumption	  in	  Europe	  2011.	  Stockholm:	  ECDC;	  2014.	  
25.	   Strom	  BL,	  Kimmel	  SE,	  Hennessy	  S,	  eds.	  Pharmacoepidemiology.	  Fifth	  ed.	  
West	  Sussex:	  Wiley	  Blackwell;	  2012.	  
26.	   Furu	  K,	  Wettermark	  B,	  Andersen	  M,	  et	  al.	  The	  Nordic	  countries	  as	  a	  cohort	  
for	  pharmacoepidemiological	  research.	  Basic	  &	  Clinical	  Pharmacology	  &	  
Toxicology.	  2010;106(2):	  86-­‐94.	  
27.	   Wettermark	  B,	  Zoega	  H,	  Furu	  K,	  et	  al.	  The	  Nordic	  prescription	  databases	  
as	  a	  resource	  for	  pharmacoepidemiological	  research	  a	  literature	  review.	  
Pharmacoepidemiology	  and	  Drug	  Safety.	  2013;22(7):	  691-­‐699.	  
28.	   Sakshaug	  S,	  Strøm	  H,	  Berg	  C,	  et	  al.	  Drug	  consumption	  in	  Norway	  2009-­‐
2013.	  Oslo:	  Norwegian	  Institute	  of	  Public	  Health;	  2014.	  
29.	   Norwegian	  Institute	  of	  Puplic	  Health.	  http://www.norpd.no.	  Norwegian	  
Institute	  of	  Puplic	  Health.	  Accessed	  28.02,	  2014.	  
30.	   Furu	  K.	  Establishment	  of	  the	  nationwide	  Norwegian	  prescription	  
database	  (NorPD)	  -­‐new	  opportunities	  for	  research	  in	  
pharmacoepidemiology	  in	  Norway.	  Norsk	  Epidemiologi.	  2008;18(2).	  
31.	   University	  of	  Bergen.	  The	  Hordaland	  health	  studies,	  http://husk-­‐
en.b.uib.no/.	  University	  of	  Bergen.	  Accessed	  24.08,	  2014.	  
32.	   Gjelstad	  S,	  Dalen	  I,	  Lindbaek	  M.	  GPs'	  antibiotic	  prescription	  patterns	  for	  
respiratory	  tract	  infections	  -­‐	  still	  room	  for	  improvement.	  Scandinavian	  
Journal	  of	  Primary	  Health	  Care.	  2009;27(4):	  208-­‐215.	  
33.	   Gjelstad	  S,	  Straand	  J,	  Dalen	  I,	  et	  al.	  Do	  general	  practitioners'	  consultation	  
rates	  influence	  their	  prescribing	  patterns	  of	  antibiotics	  for	  acute	  
respiratory	  tract	  infections?	  Journal	  of	  Antimicrobial	  Chemotherapy.	  
2011;66(10):	  2425-­‐2433.	  
	   53	  
34.	   UiT	  the	  arctic	  university	  of	  Norway.	  Tromsøundersøkelsen,	  
http://uit.no/om/enhet/artikkel?p_document_id=70715&p_dimension_id
=88111.	  UiT,	  the	  arctic	  university	  of	  Tromsø,.	  Accessed	  20.08,	  2014.	  
35.	   MacGowan	  A,	  Albur	  M.	  Frontline	  antibiotic	  therapy.	  Clinical	  medicine.	  
2013;13(3):	  263-­‐268.	  
36.	   The	  Norwegian	  directorate	  of	  health.	  Guidelines	  for	  the	  use	  of	  antibiotics	  
in	  primary	  care	  (in	  Norwegian),	  
http://www.helsebiblioteket.no/retningslinjer/antibiotika/forord;jsessio
nid=030FA29209D77D1E1EE705856F978A91?hideme=true.	  The	  
Norwegian	  directorate	  of	  health.	  Accessed	  17.06,	  2014.	  
37.	   Masiero	  G,	  Filippini	  M,	  Ferech	  M,	  et	  al.	  Socioeconomic	  determinants	  of	  
outpatient	  antibiotic	  use	  in	  Europe.	  International	  Journal	  of	  Public	  Health.	  
2010;55(5):	  469-­‐478.	  
38.	   Huttner	  B,	  Jones	  M,	  Huttner	  A,	  et	  al.	  Antibiotic	  prescription	  practices	  for	  
pneumonia,	  skin	  and	  soft	  tissue	  infections	  and	  urinary	  tract	  infections	  
throughout	  the	  US	  veterans	  affairs	  system.	  Journal	  of	  Antimicrobial	  
Chemotherapy.	  2013;68(10):	  2393-­‐2399.	  
39.	   Harbarth	  S,	  Albrich	  W,	  Brun-­‐Buisson	  C.	  Outpatient	  antibiotic	  use	  and	  
prevalence	  of	  antibiotic-­‐resistant	  pneumococci	  in	  France	  and	  Germany:	  a	  
sociocultural	  perspective.	  Emerging	  Infectious	  Diseases.	  2002;8(12):	  
1460-­‐1467.	  
40.	   Filippini	  M,	  Masiero	  G,	  Moschetti	  K.	  Socioeconomic	  determinants	  of	  
regional	  differences	  in	  outpatient	  antibiotic	  consumption:	  Evidence	  from	  
Switzerland.	  Health	  Policy.	  2006;78(1):	  77-­‐92.	  
41.	   Franchi	  C,	  Sequi	  M,	  Bonati	  M,	  et	  al.	  Differences	  in	  outpatient	  antibiotic	  
prescription	  in	  Italy's	  Lombardy	  region.	  Infection.	  2011;39(4):	  299-­‐308.	  
42.	   Bernier	  A,	  Delarocque-­‐Astagneau	  E,	  Ligier	  C,	  et	  al.	  Outpatient	  antibiotic	  
use	  in	  France	  between	  2000	  and	  2010:	  after	  the	  nationwide	  campaign,	  it	  
is	  time	  to	  focus	  on	  the	  elderly.	  Antimicrobial	  Agents	  and	  Chemotherapy.	  
2014;58(1):	  71-­‐77.	  
43.	   Mazzaglia	  G,	  Caputi	  AP,	  Rossi	  A,	  et	  al.	  Exploring	  patient-­‐	  and	  doctor-­‐
related	  variables	  associated	  with	  antibiotic	  prescribing	  for	  respiratory	  
infections	  in	  primary	  care.	  European	  Journal	  of	  Clinical	  Pharmacology.	  
2003;59(8-­‐9):	  651-­‐657.	  
44.	   Cockburn	  J,	  Pit	  S.	  Prescribing	  behaviour	  in	  clinical	  practice:	  patients'	  
expectations	  and	  doctors'	  perceptions	  of	  patients'	  expectations	  a	  
questionnaire	  study.	  BMJ.	  1997;315(7107):	  520-­‐523.	  
45.	   Lado	  E,	  Vacariza	  M,	  Fernández-­‐González	  C,	  et	  al.	  Influence	  exerted	  on	  
drug	  prescribing	  by	  patients’	  attitudes	  and	  expectations	  and	  by	  doctors’	  
perception	  of	  such	  expectations:	  a	  cohort	  and	  nested	  case-­‐control	  study.	  
Journal	  of	  Evaluation	  in	  Clinical	  Practice.	  2008;14(3):	  453-­‐459.	  
46.	   Faber	  MS,	  Heckenbach	  K,	  Velasco	  E,	  et	  al.	  Antibiotics	  for	  the	  common	  cold:	  
expectations	  of	  Germany's	  general	  population.	  Eurosurveillance.	  
2010;15(35):	  10-­‐16.	  
47.	   Fossum	  GH,	  Lindbaek	  M,	  Gjelstad	  S,	  et	  al.	  Are	  children	  carrying	  the	  burden	  
of	  broad-­‐spectrum	  antibiotics	  in	  general	  practice?	  Prescription	  pattern	  
for	  paediatric	  outpatients	  with	  respiratory	  tract	  infections	  in	  Norway.	  
British	  Medical	  Association,	  BMJ	  Open.	  2013;3(1).	  
	   54	  
48.	   Wang	  KY,	  Seed	  P,	  Schofield	  P,	  et	  al.	  Which	  practices	  are	  high	  antibiotic	  
prescribers?	  A	  cross-­‐sectional	  analysis.	  British	  Journal	  of	  General	  Practice.	  
2009;59(567):	  724-­‐727.	  
49.	   Murphy	  M,	  Bradley	  CP,	  Byrne	  S.	  The	  role	  of	  GP	  characteristics	  in	  
antimicrobial	  prescribing	  in	  Ireland.	  Pharmacoepidemiology	  and	  Drug	  
Safety.	  2010;19(6):	  654-­‐655.	  
50.	   Blommaert	  A,	  Coenen	  S,	  Gielen	  B,	  et	  al.	  Patient	  and	  prescriber	  
determinants	  for	  the	  choice	  between	  amoxicillin	  and	  broader-­‐spectrum	  
antibiotics:	  a	  nationwide	  prescription-­‐level	  analysis.	  Journal	  of	  
Antimicrobial	  Chemotherapy.	  2013;68(10):	  2383-­‐2392.	  
51.	   Mainous	  AG,	  Hueston	  WJ,	  Love	  MM.	  Antibiotics	  for	  colds	  in	  children:	  who	  
are	  the	  high	  prescribers?	  Archives	  of	  pediatrics	  &	  adolescent	  medicine.	  
1998;152(4):	  349-­‐352.	  
52.	   Cadieux	  GM,	  Tamblyn	  RP,	  Dauphinee	  DMD,	  et	  al.	  Predictors	  of	  
inappropriate	  antibiotic	  prescribing	  among	  primary	  care	  physicians.	  
Canadian	  Medical	  Association.	  Journal.	  2007;177(8):	  877-­‐883.	  
53.	   Agdestein	  B,	  Lindbak	  M,	  Gjelstad	  S.	  Do	  general	  practitioners	  follow	  the	  
national	  guidelines	  for	  treating	  urinary	  tract	  infections	  with	  antibiotics?	  
(In	  Norwegian).	  Tidsskrift	  for	  den	  Norske	  legeforening.	  2011;131(17):	  
1641-­‐1644.	  
54.	   Wood	  F,	  Simpson	  S,	  Butler	  CC.	  Socially	  responsible	  antibiotic	  choices	  in	  
primary	  care:	  a	  qualitative	  study	  of	  GPs'	  decisions	  to	  prescribe	  broad-­‐
spectrum	  and	  fluroquinolone	  antibiotics.	  Family	  practice.	  2007;24(5):	  
427-­‐434.	  
55.	   Piovani	  D,	  Clavenna	  A,	  Cartabia	  M,	  et	  al.	  The	  regional	  profile	  of	  antibiotic	  
prescriptions	  in	  Italian	  outpatient	  children.	  European	  Journal	  of	  Clinical	  
Pharmacology.	  2012;68(6):	  997-­‐1005.	  
56.	   Versporten	  A,	  Bolokhovets	  G,	  Ghazaryan	  L,	  et	  al.	  Antibiotic	  use	  in	  eastern	  
Europe:	  a	  cross-­‐national	  database	  study	  in	  coordination	  with	  the	  WHO	  
Regional	  Office	  for	  Europe.	  The	  Lancet	  Infectious	  Diseases.	  2014;	  14(5).	  
57.	   Elseviers	  MM,	  Ferech	  M,	  Vander	  Stichele	  RH,	  et	  al.	  Antibiotic	  use	  in	  
ambulatory	  care	  in	  Europe	  (ESAC	  data	  1997-­‐2002):	  trends,	  regional	  
differences	  and	  seasonal	  fluctuations.	  Pharmacoepidemiology	  and	  Drug	  
Safety.	  2007;16(1):	  115-­‐123.	  
58.	   van	  Bijnen	  EME,	  den	  Heijer	  CDJ,	  Paget	  WJ,	  et	  al.	  The	  appropriateness	  of	  
prescribing	  antibiotics	  in	  the	  community	  in	  Europe:	  study	  design.	  Bmc	  
Infectious	  Diseases.	  2011;11.	  
59.	   de	  Sande-­‐Bruinsma	  NV,	  Grundmann	  H,	  Verloo	  D,	  et	  al.	  Antimicrobial	  drug	  
use	  and	  resistance	  in	  Europe.	  Emerging	  Infectious	  Diseases.	  2008;14(11):	  
1722-­‐1730.	  
60.	   Adriaenssens	  N,	  Coenen	  S,	  Versporten	  A,	  et	  al.	  European	  surveillance	  of	  
antimicrobial	  consumption	  (ESAC):	  outpatient	  antibiotic	  use	  in	  Europe	  
(1997-­‐2009).	  Journal	  of	  Antimicrobial	  Chemotherapy.	  2011;66:	  3-­‐12.	  
61.	   Matuz	  M,	  Benko	  R,	  Doro	  P,	  et	  al.	  Regional	  variations	  in	  community	  
consumption	  of	  antibiotics	  in	  Hungary,	  1996-­‐2003.	  British	  Journal	  of	  
Clinical	  Pharmacology.	  2006;61(1):	  96-­‐100.	  
62.	   Marra	  F,	  Mak	  S,	  Chong	  M,	  et	  al.	  The	  relationship	  among	  antibiotic	  
consumption,	  socioeconomic	  factors	  and	  climatic	  conditions.	  Canadian	  
	   55	  
Journal	  of	  Infectious	  Diseases	  &	  Medical	  Microbiology.	  2010;21(3):	  E99-­‐
E106.	  
63.	   Bruinsma	  N,	  Filius	  PMG,	  De	  Smet	  P,	  et	  al.	  Antibiotic	  usage	  and	  resistance	  
in	  different	  regions	  of	  the	  Dutch	  community.	  Microbial	  Drug	  Resistance-­‐
Mechanisms	  Epidemiology	  and	  Disease.	  2002;8(3):	  209-­‐214.	  
64.	   Pastor	  Garcia	  E,	  Eiros	  Bouza	  JM,	  Mayo	  Iscar	  A,	  et	  al.	  Influence	  of	  
population	  structure	  on	  the	  consumption	  of	  systemic	  antibiotics.	  
International	  Journal	  of	  Antimicrobial	  Agents.	  2005;25(1):	  84-­‐88.	  
65.	   Koller	  D,	  Hoffmann	  F,	  Maier	  W,	  et	  al.	  Variation	  in	  antibiotic	  prescriptions:	  
is	  area	  deprivation	  an	  explanation?	  Analysis	  of	  1.2	  million	  children	  in	  
Germany.	  Infection.	  2013;41(1):	  121-­‐127.	  
66.	   Kohlhammer	  Y,	  Raspe	  H,	  Marre	  R,	  et	  al.	  Antibiotic	  treatment	  of	  
community	  acquired	  pneumonia	  varies	  widely	  across	  Germany.	  Journal	  of	  
Infection.	  2007;54(5):	  446-­‐453.	  
67.	   Kern	  WV,	  de	  With	  K,	  Nink	  K,	  et	  al.	  Regional	  variation	  in	  outpatient	  
antibiotic	  prescribing	  in	  Germany.	  Infection.	  2006;34(5):	  269-­‐273.	  
68.	   Hedin	  K,	  Andre	  M,	  Hakansson	  A,	  et	  al.	  A	  population	  based	  study	  of	  
different	  antibiotic	  prescribing	  in	  different	  areas.	  British	  Journal	  of	  
General	  Practice.	  2006;56(530):	  680-­‐685.	  
69.	   Gallini	  A,	  Taboulet	  F,	  Bourrel	  R.	  Regional	  variations	  in	  quinolone	  use	  in	  
France	  and	  associated	  factors.	  European	  Journal	  of	  Clinical	  Microbiology	  &	  
Infectious	  Diseases.	  2012;31(11):	  2911-­‐2918.	  
70.	   Achermann	  R,	  Suter	  K,	  Kronenberg	  A,	  et	  al.	  Antibiotic	  use	  in	  adult	  
outpatients	  in	  Switzerland	  in	  relation	  to	  regions,	  seasonality	  and	  point	  of	  
care	  tests.	  Clinical	  Microbiology	  and	  Infection.	  2011;17(6):	  855-­‐861.	  
71.	   Polgreen	  PM,	  Yang	  M,	  Laxminarayan	  R,	  et	  al.	  Respiratory	  fluoroquinolone	  
use	  and	  influenza.	  Infection	  control	  and	  hospital	  epidemiology	  :	  the	  official	  
journal	  of	  the	  Society	  of	  Hospital	  Epidemiologists	  of	  America.	  2011;32(7):	  
706-­‐709.	  
72.	   NORM/NORM-­‐VET.	  Usage	  of	  antimicrobial	  agents	  and	  occurrence	  of	  
antimicrobial	  resistance	  in	  Norway	  2011.	  Tromsø	  /	  Oslo	  2012.	  
73.	   Benko	  R,	  Matuz	  M,	  Doro	  P,	  et	  al.	  Hungarian	  hospital	  antibiotic	  
consumption	  at	  the	  regional	  level,	  1996-­‐2005.	  Infection.	  2009;37(2):	  133-­‐
137.	  
74.	   Blix	  HS,	  Hjellvik	  V,	  Litleskare	  I,	  et	  al.	  Cigarette	  smoking	  and	  risk	  of	  
subsequent	  use	  of	  antibacterials:	  a	  follow-­‐up	  of	  365,117	  men	  and	  women.	  
Journal	  of	  antimicrobial	  chemotherapy.	  2011;66(9):	  2159-­‐2167.	  
75.	   Borg	  MA,	  Zarb	  P,	  Scicluna	  EA,	  et	  al.	  Antibiotic	  consumption	  as	  a	  driver	  for	  
resistance	  in	  Staphylococcus	  aureus	  and	  Escherichia	  coli	  within	  a	  
developing	  region.	  American	  Journal	  of	  Infection	  Control.	  2010;38(3):	  212-­‐
216.	  
76.	   de	  With	  K,	  Steib-­‐Bauert	  M,	  Straach	  P,	  et	  al.	  Is	  there	  significant	  regional	  
variation	  in	  hospital	  antibiotic	  consumption	  in	  Germany?	  Infection.	  
2006;34(5):	  274-­‐277.	  
77.	   Filippini	  M,	  Masiero	  G,	  Moschetti	  K.	  Regional	  consumption	  of	  antibiotics:	  a	  
demand	  system	  approach.	  Economic	  Modelling.	  2009;26(6):	  1389-­‐1397.	  
78.	   Galatti	  L,	  Sessa	  A,	  Mazzaglia	  G,	  et	  al.	  Antibiotic	  prescribing	  for	  acute	  and	  
recurrent	  cystitis	  in	  primary	  care:	  a	  4	  year	  descriptive	  study.	  Journal	  of	  
Antimicrobial	  Chemotherapy.	  2006;57(3):	  551-­‐556.	  
	   56	  
79.	   Haeseker	  MB,	  Dukers-­‐Muijrers	  NH,	  Hoebe	  CJ,	  et	  al.	  Trends	  in	  antibiotic	  
prescribing	  in	  adults	  in	  Dutch	  general	  practice.	  Plos	  One.	  2012;7(12):	  
e51860.	  
80.	   Le	  Corvoisier	  P,	  Renard	  V,	  Roudot-­‐Thoraval	  F,	  et	  al.	  Long-­‐term	  effects	  of	  
an	  educational	  seminar	  on	  antibiotic	  prescribing	  by	  GPs:	  a	  randomised	  
controlled	  trial.	  The	  British	  journal	  of	  general	  practice	  :	  the	  journal	  of	  the	  
Royal	  College	  of	  General	  Practitioners.	  2013;63(612):	  e455-­‐464.	  
81.	   Meropol	  SB,	  Chen	  Z,	  Metlay	  JP.	  Reduced	  antibiotic	  prescribing	  for	  acute	  
respiratory	  infections	  in	  adults	  and	  children.	  The	  British	  journal	  of	  general	  
practice	  :	  the	  journal	  of	  the	  Royal	  College	  of	  General	  Practitioners.	  
2009;59(567):	  e321-­‐328.	  
82.	   Piovani	  D,	  Clavenna	  A,	  Bonati	  M,	  et	  al.	  Drug	  use	  profile	  in	  outpatient	  
children	  and	  adolescents	  in	  different	  Italian	  regions.	  Bmc	  Pediatrics.	  
2013;13.	  
83.	   Pulcini	  C,	  Lions	  C,	  Ventelou	  B,	  et	  al.	  Indicators	  show	  differences	  in	  
antibiotic	  use	  between	  general	  practitioners	  and	  paediatricians.	  European	  
journal	  of	  clinical	  microbiology	  &	  infectious	  diseases	  :	  official	  publication	  of	  
the	  European	  Society	  of	  Clinical	  Microbiology.	  2013;32(7):	  929-­‐935.	  
84.	   Pulcini	  C,	  Lions	  C,	  Ventelou	  B,	  et	  al.	  Approaching	  the	  quality	  of	  antibiotic	  
prescriptions	  in	  primary	  care	  using	  reimbursement	  data.	  European	  
journal	  of	  clinical	  microbiology	  &	  infectious	  diseases	  :	  official	  publication	  of	  
the	  European	  Society	  of	  Clinical	  Microbiology.	  2013;32(3):	  325-­‐332.	  
85.	   Rosman	  S,	  Le	  Vaillant	  M,	  Schellevis	  F,	  et	  al.	  Prescribing	  patterns	  for	  upper	  
respiratory	  tract	  infections	  in	  general	  practice	  in	  France	  and	  in	  the	  
Netherlands.	  European	  Journal	  of	  Public	  Health.	  2008;18(3):	  312-­‐316.	  
86.	   Thrane	  N,	  Olesen	  C,	  Schonheyder	  HC,	  et	  al.	  Multiple	  prescriptions	  of	  
antibiotics	  for	  children	  aged	  0	  to	  5	  years	  in	  relation	  to	  type	  of	  antibiotic.	  
Journal	  of	  Antimicrobial	  Chemotherapy.	  1999;44(6):	  839-­‐842.	  
87.	   Vellinga	  A,	  Murphy	  AW,	  Hanahoe	  B,	  et	  al.	  A	  multilevel	  analysis	  of	  
trimethoprim	  and	  ciprofloxacin	  prescribing	  and	  resistance	  of	  
uropathogenic	  Escherichia	  coli	  in	  general	  practice.	  Journal	  of	  Antimicrobial	  
Chemotherapy.	  2010;65(7):	  1514-­‐1520.	  
88.	   Poirel	  L,	  Bonnin	  RA,	  Nordmann	  P.	  Genetic	  basis	  of	  antibiotic	  resistance	  in	  
pathogenic	  Acinetobacter	  species.	  IUBMB	  life.	  2011;63(12):	  1061-­‐1067.	  
89.	   World	  Health	  Organization.	  Antimicrobial	  resistance,	  global	  report	  on	  
surveilance.	  Geneva:	  World	  Health	  Organization;	  2014.	  
90.	   Krueger	  AL,	  Folster	  J,	  Medalla	  F,	  et	  al.	  Commensal	  Escherichia	  coli	  isolate	  
resistant	  to	  eight	  classes	  of	  antimicrobial	  agents	  in	  the	  United	  States.	  
Foodborne	  Pathogens	  and	  Disease.	  2011;8(2):	  329-­‐332.	  
91.	   Abraham	  EP,	  Chain	  E.	  An	  enzyme	  from	  bacteria	  able	  to	  destroy	  penicillin.	  
Nature.	  1940;146:	  837-­‐837.	  
92.	   Akinbowale	  OL,	  Peng	  H,	  Barton	  MD.	  Diversity	  of	  tetracycline	  resistance	  
genes	  in	  bacteria	  from	  aquaculture	  sources	  in	  Australia.	  Journal	  of	  applied	  
microbiology.	  2007;103(5):	  2016-­‐2025.	  
93.	   Lebreton	  F,	  van	  Schaik	  W,	  McGuire	  AM,	  et	  al.	  Emergence	  of	  epidemic	  
multidrug-­‐resistant	  Enterococcus	  faecium	  from	  animal	  and	  commensal	  
strains.	  mBio.	  2013;4(4).	  
94.	   Delsol	  AA,	  Randall	  L,	  Cooles	  S,	  et	  al.	  Effect	  of	  the	  growth	  promoter	  
avilamycin	  on	  emergence	  and	  persistence	  of	  antimicrobial	  resistance	  in	  
	   57	  
enteric	  bacteria	  in	  the	  pig.	  Journal	  of	  applied	  microbiology.	  2005;98(3):	  
564-­‐571.	  
95.	   Walsh	  F,	  Duffy	  B.	  The	  culturable	  soil	  antibiotic	  resistome:	  a	  community	  of	  
multi-­‐drug	  resistant	  bacteria.	  Plos	  One.	  2013;8(6):	  e65567.	  
96.	   Flemming A.	  On the antibacterial action of cultures of a penicillium with 
special reference to their use in the isolation of B. influenzae.	  Bristish 
journal of experimental pathology.	  1929;10:	  226-236.	  
97.	   Nikaido	  H.	  Prevention	  of	  drug	  access	  to	  bacterial	  targets	  -­‐	  permeability	  
barriers	  and	  active	  efflux.	  Science.	  1994;264(5157):	  382-­‐388.	  
98.	   Cox	  G,	  Wright	  GD.	  Intrinsic	  antibiotic	  resistance:	  mechanisms,	  origins,	  
challenges	  and	  solutions.	  International	  Journal	  of	  Medical	  Microbiology.	  
2013;303(6-­‐7):	  287-­‐292.	  
99.	   Davies	  JE.	  Origins,	  acquisition	  and	  dissemination	  of	  antibiotic	  resistance	  
determinants.	  Antibiotic	  Resistance:	  Origins,	  Evolution,	  Selection	  and	  
Spread.	  1997;207:	  15-­‐27.	  
100.	   Smith	  T,	  Wolff	  KA,	  Nguyen	  L.	  Molecular	  biology	  of	  drug	  resistance	  in	  
Mycobacterium	  tuberculosis.	  Current	  topics	  in	  microbiology	  and	  
immunology.	  2013;374:	  53-­‐80.	  
101.	   de	  la	  Cruz	  F,	  Davies	  J.	  Horizontal	  gene	  transfer	  and	  the	  origin	  of	  species:	  
lessons	  from	  bacteria.	  Trends	  in	  microbiology.	  2000;8(3):	  128-­‐133.	  
102.	   Thomas	  CM,	  Nielsen	  KM.	  Mechanisms	  of,	  and	  barriers	  to,	  horizontal	  gene	  
transfer	  between	  bacteria.	  Nature	  reviews.	  Microbiology.	  2005;3(9):	  711-­‐
721.	  
103.	   Chen	  I,	  Christie	  PJ,	  Dubnau	  D.	  The	  ins	  and	  outs	  of	  DNA	  transfer	  in	  bacteria.	  
Science.	  2005;310(5753):	  1456-­‐1460.	  
104.	   Frost	  LS,	  Leplae	  R,	  Summers	  AO,	  et	  al.	  Mobile	  genetic	  elements:	  the	  agents	  
of	  open	  source	  evolution.	  Nature	  reviews.	  Microbiology.	  2005;3(9):	  722-­‐
732.	  
105.	   Mazel	  D.	  Integrons:	  agents	  of	  bacterial	  evolution.	  Nature	  Reviews	  
Microbiology.	  2006;4(8):	  608-­‐620.	  
106.	   Johnston	  C,	  Martin	  B,	  Fichant	  G,	  et	  al.	  Bacterial	  transformation:	  
distribution,	  shared	  mechanisms	  and	  divergent	  control.	  Nature	  Reviews	  
Microbiology.	  2014;12(3):	  181-­‐196.	  
107.	   Overballe-­‐Petersen	  S,	  Harms	  K,	  Orlando	  LAA,	  et	  al.	  Bacterial	  natural	  
transformation	  by	  highly	  fragmented	  and	  damaged	  DNA.	  Proceedings	  of	  
the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America.	  
2013;110(49):	  19860-­‐19865.	  
108.	   Datta	  N,	  Hughes	  VM.	  Plasmids	  of	  the	  same	  Inc	  groups	  in	  Enterobacteria	  
before	  and	  after	  the	  medical	  use	  of	  antibiotics.	  Nature.	  1983;306(5943):	  
616-­‐617.	  
109.	   Hughes	  VM,	  Datta	  N.	  Conjugative	  plasmids	  in	  bacteria	  of	  the	  pre-­‐antibiotic	  
era.	  Nature.	  1983;302(5910):	  725-­‐726.	  
110.	   Hall	  RM,	  Collis	  CM.	  Mobile	  gene	  cassettes	  and	  integrons	  -­‐	  capture	  and	  
spread	  of	  genes	  by	  site-­‐specific	  recombination.	  Molecular	  Microbiology.	  
1995;15(4):	  593-­‐600.	  
111.	   Dubey	  GP,	  Ben-­‐Yehuda	  S.	  Intercellular	  nanotubes	  mediate	  bacterial	  
communication.	  Cell.	  2011;144(4):	  590-­‐600.	  
112.	   Fulsundar	  S,	  Harms	  K,	  Flaten	  GE,	  et	  al.	  Gene	  transfer	  potential	  of	  outer	  
membrane	  vesicles	  of	  Acinetobacter	  baylyi	  and	  effects	  of	  stress	  on	  
	   58	  
vesiculation.	  Applied	  and	  Environmental	  Microbiology.	  2014;80(11):	  3469-­‐
3483.	  
113.	   Andersson	  DI,	  Hughes	  D.	  Microbiological	  effects	  of	  sublethal	  levels	  of	  
antibiotics.	  Nature	  reviews.	  Microbiology.	  2014;12(7):	  465-­‐478.	  
114.	   Johnsen	  PJ,	  Dubnau	  D,	  Levin	  BR.	  Episodic	  selection	  and	  the	  maintenance	  
of	  competence	  and	  natural	  transformation	  in	  Bacillus	  subtilis.	  Genetics.	  
2009;181(4):	  1521-­‐1533.	  
115.	   Johnsen	  PJ,	  Townsend	  JP,	  Bohn	  T,	  et	  al.	  Factors	  affecting	  the	  reversal	  of	  
antimicrobial-­‐drug	  resistance.	  Lancet	  Infectious	  Diseases.	  2009;9(6):	  357-­‐
364.	  
116.	   Andrews	  JM.	  Determination	  of	  minimum	  inhibitory	  concentrations.	  
Journal	  of	  Antimicrobial	  Chemotherapy.	  2001;48(suppl	  1):	  5-­‐16.	  
117.	   Mouton	  JW,	  Brown	  DFJ,	  Apfalter	  P,	  et	  al.	  The	  role	  of	  
pharmacokinetics/pharmacodynamics	  in	  setting	  clinical	  MIC	  breakpoints:	  
the	  EUCAST	  approach.	  Clinical	  Microbiology	  and	  Infection.	  2012;18(3):	  
E37-­‐E45.	  
118.	   Seppala	  H,	  Klaukka	  T,	  VuopioVarkila	  J,	  et	  al.	  The	  effect	  of	  changes	  in	  the	  
consumption	  of	  macrolide	  antibiotics	  on	  erythromycin	  resistance	  in	  
group	  a	  streptococci	  in	  Finland.	  New	  England	  Journal	  of	  Medicine.	  
1997;337(7):	  441-­‐446.	  
119.	   Guillemot	  D,	  Varon	  E,	  Bernede	  C,	  et	  al.	  Reduction	  of	  antibiotic	  use	  in	  the	  
community	  reduces	  the	  rate	  of	  colonization	  with	  penicillin	  G-­‐
nonsusceptible	  Streptococcus	  pneumoniae.	  Clinical	  Infectious	  Diseases.	  
2005;41(7):	  930-­‐938.	  
120.	   Hennessy	  TW,	  Petersen	  KM,	  Bruden	  D,	  et	  al.	  Changes	  in	  antibiotic-­‐
prescribing	  practices	  and	  carriage	  of	  penicillin-­‐resistant	  Streptococcus	  
pneumoniae:	  a	  controlled	  intervention	  trial	  in	  rural	  Alaska.	  Clinical	  
Infectious	  Diseases.	  2002;34(12):	  1543-­‐1550.	  
121.	   Enne	  VI,	  Livermore	  DM,	  Stephens	  P,	  et	  al.	  Persistence	  of	  sulphonamide	  
resistance	  in	  Escherichia	  coli	  in	  the	  UK	  despite	  national	  prescribing	  
restriction.	  Lancet.	  2001;357(9265):	  1325-­‐1328.	  
122.	   Johnsen	  PJ,	  Townsend	  JP,	  Bohn	  T,	  et	  al.	  Retrospective	  evidence	  for	  a	  
biological	  cost	  of	  vancomycin	  resistance	  determinants	  in	  the	  absence	  of	  
glycopeptide	  selective	  pressures.	  Journal	  of	  Antimicrobial	  Chemotherapy.	  
2011;66(3):	  608-­‐610.	  
123.	   Levin	  BR,	  Perrot	  V,	  Walker	  N.	  Compensatory	  mutations,	  antibiotic	  
resistance	  and	  the	  population	  genetics	  of	  adaptive	  evolution	  in	  bacteria.	  
Genetics.	  2000;154(3):	  985-­‐997.	  
124.	   Cabello	  FC.	  Heavy	  use	  of	  prophylactic	  antibiotics	  in	  aquaculture:	  a	  
growing	  problem	  for	  human	  and	  animal	  health	  and	  for	  the	  environment.	  
Environmental	  Microbiology.	  2006;8(7):	  1137-­‐1144.	  
125.	   Allen	  HK,	  Levine	  UY,	  Looft	  T,	  et	  al.	  Treatment,	  promotion,	  commotion:	  
antibiotic	  alternatives	  in	  food-­‐producing	  animals.	  Trends	  in	  microbiology.	  
2013;21(3):	  114-­‐119.	  
126.	   Johnning	  A,	  Moore	  ER,	  Svensson-­‐Stadler	  L,	  et	  al.	  Acquired	  genetic	  
mechanisms	  of	  a	  multiresistant	  bacterium	  isolated	  from	  a	  treatment	  plant	  
receiving	  wastewater	  from	  antibiotic	  production.	  Applied	  and	  
Environmental	  Microbiology.	  2013;79(23):	  7256-­‐7263.	  
	   59	  
127.	   R	  Development	  Core	  	  Team.	  R:	  a	  language	  and	  environment	  for	  statistical	  
computing	  [computer	  program].	  Version	  3.0.3.	  Vienna:	  R	  foundation	  for	  
statistical	  computing;	  2014.	  
128.	   Chen	  H.	  VennDiagram:	  generate	  high-­‐resolution	  Venn	  and	  Euler	  plots	  
[computer	  program].	  Version	  1.6.7;	  2014.	  
129.	   Soetaert	  K.	  Diagram:	  functions	  for	  visualising	  simple	  graphs	  (networks),	  
plotting	  flow	  diagrams	  [computer	  program].	  Version	  1.6.2;	  2014.	  
130.	   Oksanen	  J,	  Blanchet	  FG,	  Kindt	  R,	  et	  al.	  Vegan:	  community	  ecology	  package	  
[computer	  program].	  Version	  2.0-­‐7;	  2013.	  
131.	   Koenker	  R.	  Quantreg:	  quantile	  regression	  [computer	  program].	  Version	  
5.05;	  2013.	  
132.	   Soetaert	  K,	  Petzoldt	  T,	  Setzer	  WR.	  Solving	  differential	  equations	  i	  R:	  
package	  deSolve.	  Journal	  of	  statistical	  software.	  2010;33(9):	  1-­‐25.	  
133.	   Adler	  D,	  Murdock	  D.	  Rgl:	  3D	  visualization	  device	  system	  (OpenGL)	  
[computer	  program].	  Version	  0.93.996;	  2014.	  
134.	   Textor	  J,	  Hardt	  J,	  Knueppel	  S.	  DAGitty	  a	  graphical	  tool	  for	  analyzing	  causal	  
diagrams.	  Epidemiology.	  2011;22(5):	  745-­‐745.	  
135.	   IBM.	  SPSS,	  PASW	  statistics	  [computer	  program].	  Version	  21.0.0.0;	  2012.	  
136.	   Statistics	  Norway.	  http://www.ssb.no.	  Statistics	  Norway.	  Accessed	  17.04,	  
2012.	  
137.	   Bolstad	  E.	  Norske	  kommune	  -­‐og	  fylkessenter	  (Norwegian	  municipality	  
and	  county	  centers),	  
http://www.erikbolstad.no/geo/skandinavia/norske-­‐kommunesenter/.	  
Accessed	  31.03,	  2014.	  
138.	   Greenacre	  M.	  Correspondence	  analysis	  in	  medical	  research.	  Statistical	  
methods	  in	  medical	  research.	  1992;1(1):	  97-­‐117.	  
139.	   Shrier	  I,	  Platt	  RW.	  Reducing	  bias	  through	  directed	  acyclic	  graphs.	  Bmc	  
Medical	  Research	  Methodology.	  2008;8.	  
140.	   Cade	  BS,	  Noon	  BR.	  A	  gentle	  introduction	  to	  quantile	  regression	  for	  
ecologists.	  Frontiers	  in	  Ecology	  and	  the	  Environment.	  2003;1(8):	  412-­‐420.	  
141.	   Koenker	  R,	  Bassett	  G.	  Regression	  quantiles.	  Econometrica.	  1978;46(1):	  
33-­‐50.	  
142.	   Openshaw	  S.	  The	  modifiable	  areal	  unit	  problem.	  Vol	  38.	  Norwich:	  Geo	  
Books;	  1978.	  
143.	   Regoes	  RR,	  Wiuff	  C,	  Zappala	  RM,	  et	  al.	  Pharmacodynamic	  functions:	  a	  
multiparameter	  approach	  to	  the	  design	  of	  antibiotic	  treatment	  regimens.	  
Antimicrobial	  Agents	  and	  Chemotherapy.	  2004;48(10):	  3670-­‐3676.	  
144.	   Joffe	  M,	  Gambhir	  M,	  Chadeau-­‐Hyam	  M,	  et	  al.	  Causal	  diagrams	  in	  systems	  
epidemiology.	  Emerging	  themes	  in	  epidemiology.	  2012;9(1):	  1-­‐1.	  
145.	   Anderson	  RM,	  May	  RM.	  Population	  biology	  of	  infectious	  diseases	  1.	  
Nature.	  1979;280(5721):	  361-­‐367.	  
146.	   Dziurda	  D,	  Polak	  S,	  Skowron	  A,	  et	  al.	  Analysis	  of	  non-­‐hospital	  antibacterial	  
pharmacotherapy	  in	  Poland.	  International	  Journal	  of	  Infectious	  Diseases.	  
2008;12(5):	  483-­‐489.	  
147.	   Norris	  P,	  Horsburgh	  S,	  Keown	  S,	  et	  al.	  Too	  much	  and	  too	  little?	  Prevalence	  
and	  extent	  of	  antibiotic	  use	  in	  a	  New	  Zealand	  region.	  Journal	  of	  
Antimicrobial	  Chemotherapy.	  2011;66(8):	  1921-­‐1926.	  
	   60	  
148.	   Steinbakk	  M,	  Sunde	  M,	  Urdahl	  A,	  et	  al.	  Antibiotikaresistens	  -­‐	  kunnskapshull	  
/	  utfordringer	  og	  aktuelle	  tiltak	  (In	  Norwegian).	  Oslo:	  Norwegian	  institute	  
of	  public	  health;	  2014.	  
149.	   Centers	  for	  Disease	  Control	  and	  Prevention.	  Antibiotic	  resitance	  threats	  in	  
the	  United	  Sates,	  2013.	  Atlanta:	  Centers	  for	  Disease	  Controll	  and	  
Prevention;	  2013.	  
150.	   Barnett	  ML,	  Linder	  JA.	  Antibiotic	  prescribing	  for	  adults	  with	  acute	  
bronchitis	  in	  the	  United	  States,	  1996-­‐2010.	  JAMA	  :	  the	  journal	  of	  the	  
American	  Medical	  Association.	  2014;311(19):	  2020-­‐2022.	  
151.	   Smith	  R,	  Coast	  J.	  The	  true	  cost	  of	  antimicrobial	  resistance.	  Bmj-­‐British	  
Medical	  Journal.	  2013;346.	  
152.	   Laxminarayan	  R,	  Van	  Boeckel	  TP.	  The	  value	  of	  tracking	  antibiotic	  
consumption.	  Lancet	  Infectious	  Diseases.	  2014;14(5):	  360-­‐361.	  
153.	   Van	  Heirstraeten	  L,	  Coenen	  S,	  Lammens	  C,	  et	  al.	  Antimicrobial	  drug	  use	  
and	  macrolide-­‐resistant	  Streptococcus	  pyogenes,	  Belgium.	  Emerging	  
Infectious	  Diseases.	  2012;18(9):	  1515-­‐1518.	  
154.	   NORM	  /NORM-­‐VET.	  Usage	  of	  antimicrobial	  agents	  and	  occurence	  of	  
antimicrobial	  resistance	  in	  Norway	  2010.	  Tromsø	  2011.	  
155.	   DANMAP.	  DANMAP	  2008.	  Use	  of	  antimicrobial	  agents	  and	  occurrence	  of	  
antimicrobial	  resistance	  in	  bacteria	  from	  food	  animals,	  foods	  and	  humans	  
in	  Denmark.	  Copenhagen	  2008.	  
156.	   Bhopal	  RS.	  Concepts	  of	  epidemiology	  :	  integrating	  the	  ideas,	  theories,	  
principles	  and	  methods	  of	  epidemiology.	  2nd	  ed.	  ed.	  Oxford:	  Oxford	  
University	  Press;	  2008.	  
157.	   Geraci	  M.	  The	  lqmm	  package	  for	  Laplace	  quantile	  regression.	  Journal	  of	  
statistical	  Software.	  2014;(in	  press).	  
158.	   Cox	  DR.	  Principles	  of	  statistical	  inference.	  Cambridge:	  Cambridge	  
University	  Press;	  2006.	  
159.	   Burnham	  KP,	  Anderson	  DR.	  Model	  selection	  and	  multi-­‐model	  inference	  :	  a	  
practical	  information-­‐theoretic	  approach.	  2nd	  ed.	  ed.	  New	  York	  ;	  London:	  
Springer;	  2002.	  
160.	   Dayton	  MC.	  Model	  comparisons	  unsing	  information	  measures.	  Journal	  of	  
modern	  applied	  statistical	  methods.	  2003;2(2).	  
161.	   Simmering	  J.	  Stop	  using	  bivariate	  correlations	  for	  variable	  selection.	  
jacobsimmering.com.	  Vol	  2014.	  Iowa	  City;	  2014.	  
162.	   Kleinbaum	  DG,	  Kupper	  LL,	  Nizam	  A,	  et	  al.	  Applied	  regression	  analysis	  and	  
other	  multivariable	  methods.	  Belmont:	  Thomson	  Higher	  Education;	  
2008:16:36.	  
163.	   Greenland	  S,	  Pearl	  J,	  Robins	  JM.	  Causal	  diagrams	  for	  epidemiologic	  
research.	  Epidemiology.	  1999;10(1):	  37-­‐48.	  
164.	   Breitling	  LP.	  dagR:	  R	  functions	  for	  directed	  acyclic	  graphs	  [computer	  
program].	  Version	  1.1.3;	  2014.	  
165.	   Blommaert	  A,	  Marais	  C,	  Hens	  N,	  et	  al.	  Determinants	  of	  between-­‐country	  
differences	  in	  ambulatory	  antibiotic	  use	  and	  antibiotic	  resistance	  in	  
Europe:	  a	  longitudinal	  observational	  study.	  Journal	  of	  Antimicrobial	  
Chemotherapy.	  2014;69(2):	  535-­‐547.	  
166.	   Blommaert	  A,	  Hens	  N,	  Beutels	  P.	  Data	  mining	  for	  longitudinal	  data	  under	  
multicollinearity	  and	  time	  dependence	  using	  penalized	  generalized	  
	   61	  
estimating	  equations.	  Computational	  Statistics	  &	  Data	  Analysis.	  2014;71:	  
667-­‐680.	  
167.	   Everitt	  B,	  Hothorn	  T.	  An	  introduction	  to	  applied	  multivariate	  analysis	  with	  
R.	  New	  York,	  NY:	  Springer	  New	  York;	  2011.	  
168.	   Spencer	  NH.	  Essentials	  of	  multivariate	  data	  analysis.	  Boca	  Raton:	  CRC	  
Press;	  2014.	  
169.	   Strom	  BL,	  Kimmel	  SE,	  Hennesy	  S.	  The	  future	  of	  pharmacoepidemiology.	  In:	  
Strom	  BL,	  Kimmel	  SE,	  Hennesy	  S,	  eds.	  Pharmacoepidemiology.	  Fifth	  ed.	  
West	  Sussex:	  Wiley	  Blackwell;	  2012.	  
170.	   Cavallo	  P,	  Pagano	  S,	  Boccia	  G,	  et	  al.	  Network	  analysis	  of	  drug	  
prescriptions.	  Pharmacoepidemiology	  and	  Drug	  Safety.	  2013;22(2):	  130-­‐
137.	  
171.	   Temime	  L,	  Hejblum	  G,	  Setbon	  M,	  et	  al.	  The	  rising	  impact	  of	  mathematical	  
modelling	  in	  epidemiology:	  antibiotic	  resistance	  research	  as	  a	  case	  study.	  
Epidemiology	  and	  Infection.	  2008;136(3):	  289-­‐298.	  
172.	   Levin	  BR.	  Minimizing	  potential	  resistance:	  A	  population	  dynamics	  view.	  
Clinical	  Infectious	  Diseases.	  2001;33:	  S161-­‐S169.	  
173.	   Starikova	  I,	  Harms	  K,	  Haugen	  P,	  et	  al.	  A	  trade-­‐off	  between	  the	  fitness	  cost	  
of	  functional	  integrases	  and	  long-­‐term	  stability	  of	  integrons.	  PLoS	  
pathogens.	  2012;8(11):	  e1003043.	  
174.	   Box	  GEP.	  Science	  and	  statistics.	  Journal	  of	  the	  American	  Statistical	  
Association.	  1976;71(356):	  791-­‐799.	  
175.	   Wallinga	  J,	  Edmunds	  WJ,	  Kretzschmar	  M.	  Perspective:	  human	  contact	  
patterns	  and	  the	  spread	  of	  airborne	  infectious	  diseases.	  Trends	  in	  
microbiology.	  1999;7(9):	  372-­‐377.	  
176.	   McPherson	  M,	  Smith-­‐Lovin	  L,	  Cook	  JM.	  Birds	  of	  a	  feather:	  homophily	  in	  
social	  networks.	  Annual	  Review	  of	  Sociology.	  2001;27:	  415-­‐444.	  
177.	   Wright	  SW,	  Wrenn	  KD,	  Haynes	  M,	  et	  al.	  Prevalence	  and	  risk	  factors	  for	  
multidrug	  resistant	  uropathogens	  in	  ED	  patients.	  The	  American	  Journal	  of	  
Emergency	  Medicine.	  2000;18(2):	  143-­‐146.	  
178.	   Djuretic	  T,	  Herbert	  J,	  Drobniewski	  F,	  et	  al.	  Antibiotic	  resistant	  
tuberculosis	  in	  the	  United	  Kingdom:	  1993	  -­‐	  1999.	  Thorax.	  2002;57(6):	  
477-­‐482.	  
179.	   Marquess	  JMPH,	  Hu	  WP,	  Nimmo	  GRMB,	  et	  al.	  Spatial	  analysis	  of	  
community-­‐onset	  Staphylococcus	  aureus	  bacteremia	  in	  Queensland,	  
Australia.	  Infection	  Control	  and	  Hospital	  Epidemiology.	  2013;34(3):	  291-­‐
298.	  
180.	   European	  centre	  for	  disease	  prevention	  and	  control.	  Surveillance	  of	  




Paper	  I	   	  
	  
Paper	  II	  
Paper	  III	  
